This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Follow-up care involving plastic surgery
Z21_FOLLOW__CARE_INVOLVI_PLASTIC_SURGE
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
1488 |
4. Check minimum number of eventsNone |
1488 |
5. Include endpointsNone |
1488 |
6. Filter based on genotype QC (FinnGen only) |
1488 |
Control definitions (FinnGen only)
- Control exclude
- Z21_PERSONS_ENCOUNTERI_HEALTH_SERVI_SPECIFIC_PROCED_HEALTH_CARE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Z4|Z5[0-4]
Similar endpoints
↥List of similar endpoints to
Follow-up care involving plastic surgery
based on the number of shared cases.
Similar with more cases:
- Persons encountering health services for specific procedures and health care
- Factors influencing health status and contact with health services
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1488 | 1192 | 296 |
| Unadjusted period prevalence (%) | 0.35 | 0.41 | 0.13 |
| Median age at first event (years) | 54.28 | 52.60 | 61.05 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1376
- Matched controls
- 13759
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Z42.1
ICD-10 Finland
Follow-up care involving plastic surgery of breast
4127.4
323.0
749
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
12.5
240.4
476
558
HAE10
NOMESCO Finland
Reconstruction of breast using graft or flap
50.0
226.3
274
68
Z42.0
ICD-10 Finland
Follow-up care involving plastic surgery of head and neck
+∞
218.7
204
*
HAE20
NOMESCO Finland
Reconstruction of areola and mamilla using graft or flap
49.7
214.6
260
64
Z42.4
ICD-10 Finland
Follow-up care involving plastic surgery of lower extremity
+∞
205.4
192
*
HA1AA
NOMESCO Finland
X-ray mammography
10.1
203.3
452
636
HAD30
NOMESCO Finland
Reduction mammoplasty with transposition of areola
15.5
185.2
321
265
Z42.2
ICD-10 Finland
Follow-up care involving plastic surgery of other parts of trunk
+∞
178.0
167
*
TQW20
NOMESCO Finland
Tatoe
41.3
165.2
208
59
115
Kela drug reimbursment
Breast cancer
7.5
153.9
414
750
ZZF00
NOMESCO Finland
Graft of adipose tissue
51.6
149.6
180
40
HAE99
NOMESCO Finland
Other reconstruction of breast
62.4
146.0
170
31
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
8.8
140.7
330
476
HAC20
NOMESCO Finland
Total mastectomy
11.0
137.5
280
313
GD1AA
NOMESCO Finland
Thorax X-ray examination
4.2
134.4
844
3790
HA1CG
NOMESCO Finland
Extensive MRI examination of mammary gland with high intensity magnet
26.1
132.8
188
83
HAC15
NOMESCO Finland
Subcutaneous mastectomy with excision of mamilla
47.8
128.6
157
37
ZZR10
NOMESCO Finland
Flap of skin and muscle
46.5
127.9
157
38
HAE05
NOMESCO Finland
Reconstruction of breast using soft tissue and prosthesis
68.9
119.5
137
22
ZZA00
NOMESCO Finland
Split skin graft
19.7
118.2
183
106
QBE30
NOMESCO Finland
Excision and repair of surgical scar in trunk
132.4
114.0
121
10
PJA12
NOMESCO Finland
Sentinel node biopsy
6.0
111.0
346
728
N62
ICD-10 Finland
Hypertrophy of breast
9.7
109.0
235
285
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
9.6
106.4
231
283
HAE00
NOMESCO Finland
Reconstruction of breast using prosthesis
49.8
104.9
127
28
L02BA01
ATC
tamoxifen; oral
9.2
103.5
231
296
HAD50
NOMESCO Finland
Removal of prosthetic implant from breast
91.9
99.7
110
13
HAD60
NOMESCO Finland
Replacement of prosthetic implant in breast
106.4
99.5
108
11
A03FA01
ATC
metoclopramide; systemic, rectal
4.0
99.2
499
1706
Z42.3
ICD-10 Finland
Follow-up care involving plastic surgery of upper extremity
+∞
92.7
88
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
15.5
90.0
152
109
H02AB02
ATC
dexamethasone; systemic
5.3
88.8
302
687
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
7.3
88.2
227
360
WX408
NOMESCO Finland
General anesthesy, balanced
3.5
86.9
544
2179
HAD40
NOMESCO Finland
Mastopexy
56.5
80.4
95
18
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
6.4
77.9
222
402
J01DB01
ATC
cefalexin; oral
4.5
77.0
1252
9530
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
16.2
75.7
125
84
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
6.3
75.4
216
393
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
3.0
74.5
639
3112
QBE20
NOMESCO Finland
Excision and repair of scar or web of skin of trunk
32.9
74.2
98
32
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
5.8
73.7
227
452
C50.99
ICD-10 Finland
Breast, unspecified
9.2
70.4
154
186
C50
ICD-10 Finland
Malignant neoplasm of breast
10.6
70.1
141
146
ZZQ10
NOMESCO Finland
Free microvascular graft of skin and muscle
70.6
70.1
80
12
Z46.1
ICD-10 Finland
Fitting and adjustment of hearing aid
712.6
69.7
68
*
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
10.8
69.4
138
140
Z80.3
ICD-10 Finland
Family history of malignant neoplasm of breast
13.1
68.6
124
103
J01MA12
ATC
levofloxacin; systemic
3.6
68.0
372
1296
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
4.5
67.8
270
709
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
13.9
67.1
118
92
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
11.1
66.8
131
129
Z42.9
ICD-10 Finland
Follow-up care involving plastic surgery, unspecified
+∞
66.2
63
*
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
10.7
66.0
132
135
QBJ00
NOMESCO Finland
Liposuction in trunk
37.2
65.6
84
24
Z00.0
ICD-10 Finland
General medical examination
3.4
63.5
377
1387
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
5.5
62.9
200
410
X76
ICPC
Malignant neoplasm breast female
10.7
60.1
120
122
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.0
60.1
435
1833
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
3.7
58.2
290
923
Z40.0
ICD-10 Finland
Prophylactic surgery for risk-factors related to malignant neoplasms
591.8
58.1
57
*
Z31.5
ICD-10 Finland
Genetic counselling
6.0
56.5
165
303
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
8.3
55.4
128
168
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.7
55.1
269
838
S18
ICPC
Laceration/cut
2.5
55.0
666
3758
JN4BD
NOMESCO Finland
Extensive body CT
4.0
51.1
224
632
Z04.3
ICD-10 Finland
Examination and observation following other accident
10.7
49.9
99
99
NK6AN
NOMESCO Finland
Total body bone isotope imaging
8.4
49.5
113
145
J01FF01
ATC
clindamycin; systemic
2.6
49.1
475
2333
SPAT1148
SPAT
Treatment of chronic ulcer or burn
3.5
47.4
254
845
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
4.5
47.2
180
443
N02AA05
ATC
oxycodone; systemic
3.6
47.1
239
761
ZZR00
NOMESCO Finland
Flap of skin
10.2
46.9
95
99
N02BE01
ATC
paracetamol; systemic, rectal
3.3
46.5
1248
10284
L02BG04
ATC
letrozole; oral
4.1
46.2
196
534
Z03.8
ICD-10 Finland
Observation for other suspected diseases and conditions
5.7
45.4
137
260
HAD99
NOMESCO Finland
Other plastic operation on breast
26.3
45.4
63
25
SPAT1153
SPAT
Removal of sutures
2.4
45.3
530
2850
HAC10
NOMESCO Finland
Subcutaneous mastectomy with preservation of mamilla
73.8
44.3
50
7
A04AA01
ATC
ondansetron; systemic, rectal
4.6
44.1
164
393
A04AA02
ATC
granisetron; systemic, transdermal
4.9
43.8
154
348
ZSH00
NOMESCO Finland
Procedure related to previous procedure classified in chapter H
20.3
42.6
64
33
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
6.9
40.8
106
165
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
10.1
40.8
83
87
T85.4
ICD-10 Finland
Mechanical complication of breast prosthesis and implant
67.8
40.3
46
7
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
9.4
40.1
85
96
QDE35
NOMESCO Finland
Repair of skin defect in lower limb after surgery or injury
49.6
40.0
48
10
HA1CM
NOMESCO Finland
Mammary gland extensive MRI examination with 3 Tesla magnet
39.8
39.9
50
13
L91.0
ICD-10 Finland
Hypertrophic scar
13.1
39.8
71
57
Z42.8
ICD-10 Finland
Follow-up care involving plastic surgery of other body part
+∞
39.8
38
*
N64.9
ICD-10 Finland
Disorder of breast, unspecified
14.2
39.6
68
50
HAD10
NOMESCO Finland
Augmentation of breast using prosthesis
42.3
39.6
49
12
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
3.0
39.5
262
1002
HAD20
NOMESCO Finland
Liposuction of breast
66.3
39.3
45
7
TQW99
NOMESCO Finland
Other minor procedure on skin
5.2
38.2
124
256
B01AB05
ATC
enoxaparin; parenteral
2.3
37.9
474
2580
HWH99
NOMESCO Finland
Other reoperation in surgery of mammary gland
42.3
36.4
45
11
L03AA13
ATC
pegfilgrastim; parenteral
5.4
36.0
112
220
L90.5
ICD-10 Finland
Scar conditions and fibrosis of skin
19.0
35.9
55
30
HAB40
NOMESCO Finland
Wedge excision of mammary gland
3.8
35.4
162
468
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
9.3
35.4
75
85
SPAT1211
SPAT
Application of soft bandage
3.3
35.0
193
646
N64.8
ICD-10 Finland
Other specified disorders of breast
26.1
34.7
48
19
8500/2-C50.9
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS
9.8
34.6
71
76
S97
ICPC
Chronic ulcer skin
5.1
34.0
113
239
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.1
33.7
602
3779
SPAT1149
SPAT
Suture or treatment of traumatic wound
2.9
33.6
227
872
ZSZ10
NOMESCO Finland
Secondary repair operation
57.2
33.4
39
7
HWA00
NOMESCO Finland
Repair of wound dehiscence in surgery of mammary gland
34.1
33.3
43
13
JN4CD
NOMESCO Finland
Very extensive body CT
5.7
33.1
98
181
SPAT1215
SPAT
Assessment of need for medical rehabilitation
4.8
32.9
115
257
N03AX16
ATC
pregabalin; oral
2.3
32.5
381
1982
Z85.3
ICD-10 Finland
Personal history of malignant neoplasm of breast
12.6
32.1
58
48
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
7.5
31.9
77
108
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
5.1
31.9
105
220
X58
ICD-10 Finland
Exposure to other specified factors
2.8
31.7
230
923
ZXD05
NOMESCO Finland
Urgent procedure
2.1
31.7
457
2606
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.8
31.4
220
864
X59
ICD-10 Finland
Exposure to unspecified factor
2.5
31.3
290
1339
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
8.8
31.2
68
81
Z51.5
ICD-10 Finland
Palliative care
19.4
31.0
47
25
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
4.0
31.0
130
347
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
4.0
30.9
132
358
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
6.6
30.4
80
127
TQW11
NOMESCO Finland
Vacuum treatment of wound
10.8
30.4
59
57
HA1BA
NOMESCO Finland
Extensive X-ray mammography
16.5
29.9
48
30
N02AX02
ATC
tramadol; systemic, rectal
2.0
29.7
597
3865
HAB99
NOMESCO Finland
Other partial excision of mammary gland
5.6
29.4
89
169
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
5.1
29.4
96
199
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
3.9
29.3
129
359
PJW99
NOMESCO Finland
Other operation on lymphatic system
19.7
29.3
44
23
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
5.6
29.1
88
167
QB2S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in chest
16.9
29.0
46
28
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.4
29.0
283
1337
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
6.2
28.9
80
136
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.3
28.7
153
497
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
7.3
28.7
70
100
I97.2
ICD-10 Finland
Postmastectomy lymphoedema syndrome
26.7
28.5
39
15
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
6.3
28.3
77
128
H25.8
ICD-10 Finland
Other senile cataract
3.1
28.2
170
603
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
14.2
28.2
48
35
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
6.8
28.2
72
110
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
3.2
28.0
156
523
N63
ICD-10 Finland
Unspecified lump in breast
3.4
28.0
143
450
ZZS55
NOMESCO Finland
Distension of tissue expander
102.1
27.7
30
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.1
27.7
162
563
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.0
27.5
472
2853
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
8.8
27.2
59
70
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
2.7
27.2
205
838
PJ1AN
NOMESCO Finland
Lymphsystem isotope imaging
38.7
27.2
34
9
A02BC02
ATC
pantoprazole; systemic
1.9
27.1
919
7078
SPAT1229
SPAT
Assessment of need for aid
3.3
26.2
142
466
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
3.5
26.1
127
384
JN4AD
NOMESCO Finland
Body CT examination
3.5
25.7
126
383
ZXE30
NOMESCO Finland
More than five and less than seven hours
4.5
25.7
94
220
X21
ICPC
Breast sympt/compl female other
6.5
25.1
66
105
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
4.7
25.0
87
194
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
14.4
24.9
42
30
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
9.6
24.9
51
55
T81.8
ICD-10 Finland
Other complications of procedures, not elsewhere classified
7.7
24.8
58
78
HWD00
NOMESCO Finland
Reoperation for deep haemorrhage in surgery of mammary gland
11.9
24.5
45
39
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
17.7
24.5
38
22
TQB05
NOMESCO Finland
Puncture of skin of trunk
11.3
24.5
46
42
C50.89
ICD-10 Finland
Overall malignant tumor of the mammary gland, other or undeterminated histology
13.0
24.5
43
34
TQW40
NOMESCO Finland
Remowal of suture of skin
3.3
24.3
131
428
C03CA01
ATC
furosemide; systemic
2.1
24.3
334
1828
AA1AD
NOMESCO Finland
CT of head and brain
2.1
24.2
315
1685
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.0
24.1
401
2371
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.2
24.1
288
1486
SPAT1216
SPAT
Assessment of functional ability
2.4
24.0
224
1023
NH1BA
NOMESCO Finland
Ankle extensive X-ray examination
5.5
24.0
72
136
HAD55
NOMESCO Finland
Incision of periprosthetic capsule of breast
127.2
23.6
25
*
L02BG03
ATC
anastrozole; oral
6.1
23.6
65
110
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.4
23.5
221
1016
N06AX16
ATC
venlafaxine; oral
2.3
23.4
239
1143
QAE20
NOMESCO Finland
Excision and repair of scar or web of skin of head or neck
34.0
23.4
30
9
ZXA10
NOMESCO Finland
Bilateral
2.2
23.3
280
1443
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.6
23.3
182
756
SPAT1263
SPAT
Sampling
1.8
23.3
588
4019
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
6.5
23.3
61
97
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.8
23.1
734
5394
C50.82
ICD-10 Finland
Overall malignant tumor of the mammary gland, lobular tumor
10.1
23.1
46
47
HA1BG
NOMESCO Finland
MRI examination of mammary gland with high intensity magnet
9.7
23.1
47
50
ZSN00
NOMESCO Finland
Procedure related to previous procedure classified in chapter N
25.1
23.1
32
13
QBB05
NOMESCO Finland
Revision of wound of skin of trunk
13.2
23.0
40
31
L02BG06
ATC
exemestane; oral
7.2
22.8
56
81
TNX33
NOMESCO Finland
Custom moulded cast, unspecified region
3.8
22.7
99
273
L98.9
ICD-10 Finland
Disorder of skin and subcutaneous tissue, unspecified
7.0
22.5
56
83
HA1DG
NOMESCO Finland
Very extensive MRI examination of mammary gland with high intensity magnet
8.8
22.4
48
56
A04AD12
ATC
aprepitant; systemic
5.8
22.4
64
114
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
7.9
21.9
50
65
NF1AA
NOMESCO Finland
Hip X-ray examination
2.9
21.9
146
549
N05BA04
ATC
oxazepam; oral
1.9
21.8
370
2191
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.8
21.7
632
4488
HAD57
NOMESCO Finland
Resection of periprosthetic capsule of breast
223.3
21.6
22
*
ZZS00
NOMESCO Finland
Rotation flap
116.8
21.6
23
*
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.7
21.5
155
611
EP1AE
NOMESCO Finland
Neck ultrasound examination
3.4
21.4
108
336
ZZR30
NOMESCO Finland
Flap of muscle
50.8
21.2
25
5
NB1BA
NOMESCO Finland
Shoulder extensive X-ray examination without contrast
4.5
21.1
77
180
TNX32
NOMESCO Finland
Custom moulded splint, unspecified region
3.8
21.0
93
260
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
4.7
21.0
73
163
S77
ICPC
Malignant neoplasm of skin
10.8
20.9
40
38
XX2AT
NOMESCO Finland
Other injection with ultrasound examination
6.4
20.8
55
89
A46
ICD-10 Finland
Erysipelas
2.4
20.7
192
873
E0000UV
ATC
NA
1.7
20.6
562
3891
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.8
20.4
142
548
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
4.2
20.3
78
192
L02AE03
ATC
goserelin; implant
8.3
20.3
45
56
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.1
19.9
246
1278
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
5.7
19.9
58
106
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.8
19.8
425
2715
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
15.6
19.8
32
21
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
4.3
19.7
75
183
QBJ30
NOMESCO Finland
Correction of abdominal apron
10.8
19.5
37
35
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.8
19.2
374
2311
ZXE40
NOMESCO Finland
More than seven and less than nine hours
5.7
19.2
55
99
QDG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of lower limb
12.4
19.1
34
28
A04AA55
ATC
palonosetron, combinations; systemic
4.1
19.1
75
189
SPAT1172
SPAT
Guidance concerning hydration
6.4
19.1
50
80
L28
ICPC
Limited function/disability (L)
2.2
19.1
213
1057
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
3.2
19.1
105
349
ND1BA
NOMESCO Finland
Wrist extensive X-ray examination
4.7
19.0
65
143
R60.0
ICD-10 Finland
Localized oedema
2.4
18.9
174
785
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.4
18.8
176
800
Z45.0
ICD-10 Finland
Adjustment and management of cardiac devices
+∞
18.8
18
*
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
3.7
18.8
85
243
A87
ICPC
Complication of medical treatment
12.5
18.6
33
27
HA1TE
NOMESCO Finland
Supplementary or limited ultrasound examination of mammary glands
8.0
18.6
42
54
ZZS10
NOMESCO Finland
Transposition flap
101.4
18.6
20
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
4.8
18.6
62
133
N05CF01
ATC
zopiclone; oral
1.8
18.5
442
2911
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
4.4
18.5
68
161
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.9
18.4
345
2094
WX320
NOMESCO Finland
Spinalanesthesy
1.9
18.4
308
1795
HAD00
NOMESCO Finland
Augmentation mammoplasty
44.6
18.3
22
5
LAF11
NOMESCO Finland
Laparoscopic bilateral salpingo-oophorectomy
3.1
18.2
105
361
HA2AT
NOMESCO Finland
Cytology of mammary gland with ultrasound guidance
12.6
18.1
32
26
DAX08
NOMESCO Finland
Fitting of hearing aid
5.9
17.9
50
87
QBG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of trunk
27.1
17.8
24
9
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.5
17.8
143
601
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.9
17.6
329
1990
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
6.6
17.6
45
70
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
3.7
17.3
78
222
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.7
17.3
554
3957
M01AE02
ATC
naproxen; oral, rectal
1.6
17.3
794
6254
NG1BA
NOMESCO Finland
Knee extensive X-ray examination
5.3
17.2
53
104
DAX00
NOMESCO Finland
Adjustment or review of hearing aid
5.1
17.1
54
109
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
3.5
17.0
81
242
Z01.8
ICD-10 Finland
Other specified special examinations
1.9
16.9
296
1749
UJF30
NOMESCO Finland
Ileoscopy through colon
2.4
16.8
149
659
NG2AA
NOMESCO Finland
Patella X-ray examination
4.4
16.8
61
143
Z41.1
ICD-10 Finland
Other plastic surgery for unacceptable cosmetic appearance
64.1
16.8
19
*
HA013
NOMESCO Finland
Radiotherapy after total ablation of mammary gland
5.5
16.7
49
91
SPAT1310
SPAT
Counselling related to known health issue
1.7
16.3
437
2953
Z54.0
ICD-10 Finland
Convalescence following surgery
11.3
16.3
30
27
A02BC05
ATC
esomeprazole; systemic
1.6
16.2
565
4107
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
6.0
16.1
44
75
ZSZ00
NOMESCO Finland
Primary repair operation
48.1
16.0
19
*
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
7.6
16.0
37
50
N64.5
ICD-10 Finland
Other signs and symptoms in breast
4.5
15.9
56
128
D48.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Connective and other soft tissue
5.3
15.8
48
93
NG4AA
NOMESCO Finland
Lower leg X-ray examination
4.4
15.8
57
133
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
5.0
15.8
51
106
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
4.5
15.7
56
129
CS494
NOMESCO Finland
Other visual field testing
5.1
15.7
49
98
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
2.7
15.7
108
415
Z89.5
ICD-10 Finland
Acquired absence of leg at or below knee
+∞
15.6
15
*
PD1AD
NOMESCO Finland
CT of abdominal aorta and branches
13.9
15.5
26
19
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
6.9
15.5
38
56
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
5.6
15.5
45
83
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
5.4
15.4
46
88
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
8.1
15.3
34
43
R50.9
ICD-10 Finland
Fever, unspecified
2.1
15.3
178
894
H02AB04
ATC
methylprednisolone; systemic
2.0
15.3
223
1228
HAC25
NOMESCO Finland
Radical mastectomy
13.2
15.2
26
20
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
4.3
15.2
56
134
QDE20
NOMESCO Finland
Excision and repair of scar or web of skin of lower limb
45.5
15.1
18
*
J01DA01
ATC
[U] cefalexin; systemic
1.6
15.0
860
7042
T81.9
ICD-10 Finland
Unspecified complication of procedure
5.7
15.0
43
78
L03AA14
ATC
lipegfilgrastim; parenteral
4.9
14.8
48
101
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
6.2
14.7
39
64
L02BA03
ATC
fulvestrant; parenteral
18.6
14.7
22
12
JN6AD
NOMESCO Finland
CT of torso and neck
8.2
14.6
32
40
L89
ICD-10 Finland
Decubitus ulcer and pressure area
6.8
14.5
36
54
SPAT1234
SPAT
Support of social functional capacity
3.2
14.5
77
250
HAB00
NOMESCO Finland
Excision of lesion of mammary gland
3.8
14.5
62
170
JN3AD
NOMESCO Finland
Abdominal CT examination
2.6
14.5
108
436
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.6
14.4
563
4176
NK6BN
NOMESCO Finland
Bone dynamic isotope examination
22.5
14.2
20
9
Z80.4
ICD-10 Finland
Family history of malignant neoplasm of genital organs
13.5
14.2
24
18
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
2.2
14.2
146
693
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
3.0
14.1
85
299
M05BA04
ATC
alendronic acid; oral
2.4
14.1
121
528
WX110
NOMESCO Finland
Local anesthesy
1.6
14.0
890
7403
N06AX11
ATC
mirtazapine; oral
1.6
14.0
425
2948
HA3AT
NOMESCO Finland
Pucture of mammary gland cyst with ultrasound examination
7.6
14.0
32
43
C50.93
ICD-10 Finland
Malignant tumor in other specified localization in mammary gland other or unspecified histology
30.3
13.9
18
6
SPAT1254
SPAT
Administration of medicine
2.0
13.9
183
969
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
3.3
13.8
70
220
ZZS50
NOMESCO Finland
Insertion of tissue expander
53.9
13.8
16
*
PH2DE
NOMESCO Finland
Ultrasound examination of bloodflow in veins of lower extremity with Doppler method
3.7
13.8
60
167
E000001
ATC
NA
1.8
13.8
277
1702
SPAT1231
SPAT
Assessment of adjustments needed in living environment
5.9
13.8
38
66
WX100
NOMESCO Finland
Conjunctival surface anesthesia
2.2
13.7
143
684
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
4.8
13.6
45
97
QCJ00
NOMESCO Finland
Liposuction in upper limb
+∞
13.6
13
*
WZA90
NOMESCO Finland
Other doctors statement
1.7
13.5
302
1918
N06AB04
ATC
citalopram; systemic
1.7
13.5
308
1969
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
7.5
13.5
31
42
L03AA02
ATC
filgrastim; parenteral
4.5
13.5
47
107
M05BX04
ATC
denosumab; parenteral
3.0
13.4
78
271
CBB20
NOMESCO Finland
Correction of lax skin of eyelid and resection of herniated fat
6.7
13.3
33
50
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.2
13.1
142
691
I78.1
ICD-10 Finland
Naevus, non-neoplastic
4.1
13.1
51
129
9729
FHL
Other measure in this category
15.2
13.1
21
14
ZXA05
NOMESCO Finland
Left side
1.7
13.1
307
1974
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.4
13.1
111
480
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
3.2
13.0
70
230
XG410
NOMESCO Finland
Flow-volume spirometry
3.2
13.0
70
230
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.2
13.0
143
699
ZXE20
NOMESCO Finland
More than three and less than five hours
2.0
13.0
166
864
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.3
13.0
122
556
M01AE01
ATC
ibuprofen; systemic, rectal
1.9
13.0
1227
11211
C50.50
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, no histological veryfication
11.7
12.8
23
20
C50.00
ICD-10 Finland
Malignant tumor of nipple and areola, no histological veryfication
9.1
12.7
26
29
NK1AT
NOMESCO Finland
Muscle biopsy with ultrasound guidance
15.6
12.6
20
13
S82
ICPC
Naevus/mole
2.0
12.6
173
929
QWF00
NOMESCO Finland
Reoperation for insufficiency of suture in plastic surgery of skin
32.3
12.6
16
5
H02AB07
ATC
prednisone; oral
1.9
12.5
200
1135
Z49.1
ICD-10 Finland
Extracorporeal dialysis
+∞
12.5
12
*
NA1AD
NOMESCO Finland
Cervical spine CT examination
3.4
12.5
61
187
9725
FHL
Reconstruction of the mammary gland with foreign material (after removal)
24.5
12.5
17
7
M86.9
ICD-10 Finland
Osteomyelitis, unspecified
13.3
12.4
21
16
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
2.7
12.4
86
334
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.1
12.3
68
228
D82
ICPC
Teeth/gum disease
1.6
12.3
465
3387
R32
ICD-10 Finland
Unspecified urinary incontinence
3.8
12.3
51
137
HA1DM
NOMESCO Finland
Mammary gland very extensive MRI examination with 3 Tesla magnet
37.9
12.2
15
*
QBE35
NOMESCO Finland
Repair of skin defect in trunk after surgery or injury
37.9
12.2
15
*
ZX112
NOMESCO Finland
Subcutaneous
5.0
12.2
38
77
J01MA02
ATC
ciprofloxacin; systemic
1.6
12.2
471
3448
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
2.9
12.2
75
270
QWD00
NOMESCO Finland
Reoperation for superficial haemorrhage in surgery of skin
16.0
12.1
19
12
J01MA01
ATC
ofloxacin; systemic
2.2
12.1
125
593
H54.2
ICD-10 Finland
Moderate visual impairment, binocular
11.2
12.0
22
20
TPH04
NOMESCO Finland
Cathetrisation of vein
1.8
12.0
230
1387
Z97.4
ICD-10 Finland
Presence of external hearing-aid
5.6
12.0
34
62
Z01.2
ICD-10 Finland
Dental examination
1.5
11.9
539
4085
SPAT1296
SPAT
Other function in accordance with occupational therapy nomenclature
6.9
11.9
29
43
NH1CG
NOMESCO Finland
Ankle and foot extensive MRI examination with high intensity magnet
5.0
11.9
37
75
8720/3-C44.7
ICD-O-3
Malignant melanoma, NOS, of skin of lower limb and hip
11.8
11.8
21
18
Z09.0
ICD-10 Finland
Follow-up examination after surgery for other conditions
2.1
11.8
143
727
ND1AA
NOMESCO Finland
Wrist X-ray examination
2.5
11.8
97
411
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
8.5
11.8
25
30
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.0
11.8
153
801
8500/3-C50.5
ICD-O-3
Infiltrating duct carcinoma, NOS, of lower-outer quadrant of breast
7.4
11.7
27
37
WX002
NOMESCO Finland
Sedation and analgesia
1.8
11.7
235
1438
N05CF02
ATC
zolpidem; oral
1.7
11.7
252
1575
NFR20
NOMESCO Finland
Incomplete excision of soft tissue tumour of hip or thigh
16.6
11.7
18
11
ZSQ00
NOMESCO Finland
Procedure related to previous procedure classified in chapter Q
65.5
11.6
13
*
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
2.4
11.6
97
418
NHQ30
NOMESCO Finland
Amputation of foot, transmetatarsal
19.1
11.6
17
9
PD1BD
NOMESCO Finland
Extensive CT of abdominal aorta and branches
11.2
11.5
21
19
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
8.7
11.5
24
28
M03BX02
ATC
tizanidine; oral
1.5
11.5
841
7050
I89.0
ICD-10 Finland
Lymphoedema, not elsewhere classified
10.1
11.5
22
22
NH1AD
NOMESCO Finland
Ankle and foot CT
4.3
11.4
41
97
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.2
11.4
120
575
C50.9
ICD-10 Finland
Malignant neoplasm: Breast, unspecified
11.9
11.3
20
17
HA1SA
NOMESCO Finland
Expansion mammography
11.9
11.3
20
17
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
3.9
11.3
46
122
NGQ20
NOMESCO Finland
Amputation of lower leg
15.2
11.3
18
12
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
8.4
11.3
24
29
C50.92
ICD-10 Finland
Malignant tumor in another specified localization in lobular gland, lobular tumor
10.6
11.3
21
20
SPAT1312
SPAT
General health counselling
1.6
11.2
413
2980
AA1XD
NOMESCO Finland
Other special CT of head and brain
20.2
11.1
16
8
L14
ICPC
Leg/thigh symptom/complaint
2.3
11.1
104
472
TNX50
NOMESCO Finland
Removal of cutom molded cast and internal stretch
2.8
11.1
71
263
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
3.9
11.0
44
115
Z04
ICD-10 Finland
Examination and observation for other reasons
4.9
11.0
35
73
NA3DG
NOMESCO Finland
Lumbar spine very extensive MRI examination with high intensity magnet
10.1
11.0
21
21
CKW99
NOMESCO Finland
Other operation on choroid, vitreous body and retina
14.0
11.0
18
13
192
Kela drug reimbursment
Fulvestrant
14.0
11.0
18
13
M01AH05
ATC
etoricoxib; oral
1.5
10.9
791
6585
A99
ICPC
Disease/condition unspecnature/site
2.2
10.9
110
518
N02AJ06
ATC
codeine and paracetamol; systemic
1.5
10.9
458
3399
NJ3NA
NOMESCO Finland
Measurement of difference in extremity lengty with X-ray
4.2
10.9
40
97
L57.0
ICD-10 Finland
Actinic keratosis
2.1
10.9
119
581
WX722
NOMESCO Finland
PEEP
2.9
10.8
64
226
C50.20
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication
8.3
10.8
23
28
WD205
NOMESCO Finland
Therapy of methastized malignancy with hormones
8.3
10.8
23
28
ZZA50
NOMESCO Finland
Full thickness skin graft
10.7
10.8
20
19
NJ2MA
NOMESCO Finland
Measurement of mechanical axis of lower leg with X-ray
2.3
10.8
99
446
Y83.4
ICD-10 Finland
Other reconstructive surgery as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
18.0
10.7
16
9
M79.1
ICD-10 Finland
Myalgia
1.9
10.7
175
999
EB1BA
NOMESCO Finland
Extensive intraoral X-ray examination
13.0
10.7
18
14
WF003
NOMESCO Finland
Adjuvant radiotherapy
3.0
10.6
61
210
QCE20
NOMESCO Finland
Excision and repair of scar or web of skin of upper limb
60.4
10.6
12
*
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.1
10.6
126
636
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
3.5
10.6
48
140
C50.10
ICD-10 Finland
Malignant tumor of the central part of the mammary gland, no histological veryfication
10.1
10.5
20
20
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
7.4
10.5
24
33
L01BC06
ATC
capecitabine; oral
3.3
10.5
52
163
WX882
NOMESCO Finland
High dependency care
4.0
10.4
40
101
Z49.0
ICD-10 Finland
Preparatory care for dialysis
110.8
10.4
11
*
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
3.0
10.4
59
201
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
3.3
10.4
52
164
QDJ00
NOMESCO Finland
Liposuction in lower extremity
32.8
10.3
13
*
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.5
10.3
398
2888
C50.12
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,lobular tumor
9.6
10.3
20
21
S29
ICPC
Skin symptom/complaint other
1.7
10.2
209
1282
ZXE00
NOMESCO Finland
One hour or less
0.6
10.2
268
3776
HA1HA
NOMESCO Finland
Tomosynthesis mammography
7.5
10.2
23
31
WF049
NOMESCO Finland
Radiotherapy of metastasis
4.2
10.2
37
89
GA5AA
NOMESCO Finland
Rib X-ray examination
13.2
10.2
17
13
C50.4
ICD-10 Finland
Malignant neoplasm: Upper-outer quadrant of breast
5.3
10.2
30
58
R23.8
ICD-10 Finland
Other and unspecified skin changes
1.7
10.1
202
1231
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
2.4
10.1
84
362
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
3.4
10.0
47
141
SPAT1167
SPAT
Insertion of urinary catheter
3.7
10.0
42
115
R52.2
ICD-10 Finland
Other chronic pain
3.1
10.0
53
174
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.4
10.0
87
383
NG1CG
NOMESCO Finland
Knee and lower leg extensive MRI examination with high intensity magnet
3.7
9.9
42
116
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
3.7
9.9
42
116
A02BC04
ATC
rabeprazole; oral
2.0
9.9
121
619
UKC02
NOMESCO Finland
Cystoscopy
1.8
9.8
164
942
H02.3
ICD-10 Finland
Blepharochalasis
2.3
9.8
88
393
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.9
9.8
149
830
NE1AD
NOMESCO Finland
Pelvis and hip bones CT examination
5.0
9.7
30
61
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
3.7
9.7
41
113
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
3.4
9.7
45
134
N05CD07
ATC
temazepam; oral
1.9
9.7
143
785
S76
ICPC
Skin infection other
2.6
9.7
72
291
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
5.6
9.7
27
49
N05AH04
ATC
quetiapine; oral
1.7
9.7
196
1199
Q85.00
ICD-10 Finland
Neurofibromatosis, type 1
55.4
9.7
11
*
PD4DE
NOMESCO Finland
Lower extremity artery ultrasound examination with Doppler method
5.7
9.5
26
46
C50.80
ICD-10 Finland
Overall malignant tumor of the mammary gland, no histological veryfication
15.1
9.5
15
10
M01AX17
ATC
nimesulide; oral
1.6
9.5
323
2270
XF400
NOMESCO Finland
ECG with 12 standard connections
1.8
9.5
180
1080
QCG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of upper limb
100.6
9.4
10
*
E11.5
ICD-10 Finland
Type 2 diabetes mellitus, with peripheral circulatory complications
5.2
9.4
28
55
J05AB11
ATC
valaciclovir; oral
1.8
9.4
174
1034
ZZQ30
NOMESCO Finland
Free microvascular graft of muscle
+∞
9.4
9
*
ZZQ70
NOMESCO Finland
Free microvascular graft of lymph nodes
+∞
9.4
9
*
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
2.4
9.3
79
344
C50.59
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, other or undeterminated histology
8.7
9.3
19
22
B29
ICPC
Lymph/immune mech sympt/complt other
8.7
9.3
19
22
C43.59
ICD-10 Finland
Malignant melanoma of the trunk other or unspecified histology
9.6
9.3
18
19
ZXA00
NOMESCO Finland
Right side
1.5
9.2
315
2212
A08
ICPC
Swelling
2.8
9.2
58
213
SPAT1360
SPAT
Extensive global examination
2.2
9.2
96
459
J01EA01
ATC
trimethoprim; systemic
1.5
9.2
346
2487
SPAT1152
SPAT
Removal of foreign body from under the skin
3.4
9.2
43
130
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.5
9.1
452
3444
J20
ICD-10 Finland
Acute bronchitis
1.9
9.1
131
714
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.4
9.1
78
341
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
1.9
9.1
133
732
QBA10
NOMESCO Finland
Incision of skin of trunk
5.4
9.1
26
49
NH2AA
NOMESCO Finland
Heel X-ray examination
8.4
9.1
19
23
C43.79
ICD-10 Finland
Malignant melanoma of the lower extremity including hip or other unspecified histology
11.5
9.1
16
14
SPAT1151
SPAT
Treatment of major wounds
5.9
9.1
24
41
D48.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Breast
3.7
9.1
38
105
J01CA08
ATC
pivmecillinam; oral
1.4
9.0
594
4778
B01AF01
ATC
rivaroxaban; oral
1.9
9.0
136
754
QWA00
NOMESCO Finland
Repair of wound dehiscence in surgery of skin
10.1
9.0
17
17
ZX120
NOMESCO Finland
Intravenous
2.1
9.0
104
521
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
2.0
9.0
110
562
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
2.0
9.0
110
566
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
3.9
8.9
35
91
QAE30
NOMESCO Finland
Excision and repair of surgical scar in head or neck
24.2
8.9
12
5
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
5.8
8.9
24
42
Q83.8
ICD-10 Finland
Other congenital malformations of breast
12.6
8.9
15
12
C43.53
ICD-10 Finland
Malignant melanoma of the torso nodular
12.6
8.9
15
12
FM1FN
NOMESCO Finland
Heart function isotope examination
8.0
8.9
19
24
XF640
NOMESCO Finland
NA
3.2
8.8
45
145
M81.9
ICD-10 Finland
Osteoporosis, unspecified
2.8
8.8
56
208
PD4BC
NOMESCO Finland
Extensive arterigography of lower extremity with X-ray
6.4
8.8
22
35
C50.19
ICD-10 Finland
Malignant tumor of the central part of the mammary gland, other or undeterminated histology
9.5
8.8
17
18
NF3AA
NOMESCO Finland
Femur X-ray examination
4.4
8.7
30
69
W22
ICD-10 Finland
Striking against or struck by other object(s)
2.5
8.7
69
288
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.5
8.7
67
278
QDG30
NOMESCO Finland
Delayed skin closure of surgical wound in lower limb
50.3
8.7
10
*
ZXK00
NOMESCO Finland
Conversion from percutaneous endoscopic to open procedure
6.6
8.7
21
32
N06AA09
ATC
amitriptyline; systemic
1.8
8.6
138
782
R06.0
ICD-10 Finland
Dyspnoea
1.5
8.6
284
1978
J01CA04
ATC
amoxicillin; systemic
1.5
8.6
1051
9453
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
2.8
8.6
52
188
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
2.1
8.6
101
510
C50.29
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology
5.8
8.6
23
40
NK4EA
NOMESCO Finland
Joint X-ray examintion with load or wrench not elsewhere classified
5.8
8.6
23
40
HA6BA
NOMESCO Finland
Breast tomosynthesis specimen
4.2
8.6
31
75
K03.66
ICD-10 Finland
Tooth plaque
2.2
8.6
85
399
QBA00
NOMESCO Finland
Puncture of skin of trunk
11.6
8.6
15
13
TQX05
NOMESCO Finland
Skin puncture, unspecified location
11.6
8.6
15
13
C50.31
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor
4.5
8.6
29
66
R22.4
ICD-10 Finland
Localized swelling, mass and lump, lower limb
3.4
8.6
40
121
1744A
ICD-9 Finland
Malignant neoplasm of female breast, Upper-outer quadrant
7.0
8.5
20
29
C44.10
ICD-10 Finland
Malignant tumor of the skin of the eyelids including the corner of the eye without histology
9.0
8.5
17
19
B03XA02
ATC
darbepoetin alfa; parenteral
10.1
8.5
16
16
N03AX12
ATC
gabapentin; oral
1.7
8.5
181
1123
M25.5
ICD-10 Finland
Pain in joint
1.5
8.5
376
2795
Z50.1
ICD-10 Finland
Other physical therapy
5.2
8.5
25
49
QAJ30
NOMESCO Finland
Other facelift
20.1
8.5
12
6
QBE99
NOMESCO Finland
Other excision or repair of lesion of skin of trunk
3.6
8.5
36
101
ACC19
NOMESCO Finland
Transcision of peripheral nerve: other or unspecified
6.0
8.5
22
37
NHQ40
NOMESCO Finland
Amputation of toe
5.7
8.4
23
41
N05BA01
ATC
diazepam; systemic, rectal
1.7
8.4
161
968
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
3.5
8.4
37
107
D05.0
ICD-10 Finland
Lobular carcinoma in situ
12.8
8.4
14
11
9707
FHL
Ablation of mammae and removal of axillary lymph nodes
7.9
8.4
18
23
PD2BD
NOMESCO Finland
Extensive CT angiography of pelvic organs
+∞
8.3
8
*
QDG99
NOMESCO Finland
Other operation for chronic ulcer or fistula of skin of lower limb
+∞
8.3
8
*
V03AE01
ATC
polystyrene sulfonate; oral
8.6
8.3
17
20
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.6
8.2
228
1520
C43.73
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip nodular
14.6
8.2
13
9
NC1AA
NOMESCO Finland
Elbow X-ray examination without contrast
3.1
8.2
43
142
N03AE01
ATC
clonazepam; systemic
2.2
8.2
77
353
R5130
NOMESCO Finland
Repair work or maintenance done on the aid
4.1
8.2
30
74
1CD02
NOMESCO Finland
NA
5.2
8.2
24
47
J37.0
ICD-10 Finland
Chronic laryngitis
2.7
8.2
54
207
SPAT1125
SPAT
Stoma care and guidance
6.1
8.2
21
35
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
2.2
8.1
77
355
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.0
8.1
104
546
S79
ICPC
Neoplasm skin benign/unspecified
4.1
8.1
30
75
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
4.1
8.1
30
75
L57.4
ICD-10 Finland
Cutis laxa senilis
17.3
8.1
12
7
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
17.3
8.1
12
7
ZXD40
NOMESCO Finland
Procedure on patient requiring isolation
11.8
8.1
14
12
C43.70
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip without histology
11.8
8.1
14
12
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
9.0
8.0
16
18
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
9.0
8.0
16
18
ZXM40
NOMESCO Finland
Use of fluorescent substance
22.1
8.0
11
5
Z04.5
ICD-10 Finland
Examination and observation following other inflicted injury
22.1
8.0
11
5
HAB50
NOMESCO Finland
Partial excision of mammary gland with reconstructive operation
3.1
8.0
42
139
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
4.0
8.0
30
76
L13
ICPC
Hip symptom/complaint
1.6
8.0
199
1291
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
2.0
8.0
94
476
E66.01
ICD-10 Finland
Obesity due to excess calories
2.0
7.9
106
561
SPAT1324
SPAT
Screening procedure
0.6
7.9
135
2105
J01MA14
ATC
moxifloxacin; systemic
1.9
7.9
108
578
GD1AD
NOMESCO Finland
Thorax CT examination
2.8
7.9
50
184
NG1BG
NOMESCO Finland
Knee and lower leg MRI examination with high intensity magnet
2.6
7.9
55
217
TKC20
NOMESCO Finland
Catheterisation of bladder
2.3
7.9
68
301
WW200
SPAT
NA
0.4
7.9
39
874
M79.6
ICD-10 Finland
Pain in limb
1.4
7.9
437
3385
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
4.3
7.8
27
63
Z11.3
ICD-10 Finland
Special screening examination for infections with a predominantly sexual mode of transmission
2.3
7.8
69
307
QDA10
NOMESCO Finland
Incision of skin of lower limb
9.5
7.8
15
16
H25.0
ICD-10 Finland
Senile incipient cataract
2.2
7.8
79
375
8090/3-C44.1
ICD-O-3
Basal cell carcinoma, NOS, of eyelid
7.0
7.8
18
26
NH1BG
NOMESCO Finland
Ankle and foot MRI examination with high intensity magnet
3.7
7.8
32
88
NG1DG
NOMESCO Finland
Knee and lower leg very extensive MRI examination with high intensity magnet
15.1
7.7
12
8
C43.49
ICD-10 Finland
Malignant melanoma of the scalp and neck other or unspecified histology
45.2
7.7
9
*
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.7
7.7
147
883
XX3DW
NOMESCO Finland
Time consuming IT work
1.8
7.6
121
686
HA1DA
NOMESCO Finland
Restricted mammography
18.5
7.6
11
6
8720/3-C44.5
ICD-O-3
Malignant melanoma, NOS, of skin of trunk
8.1
7.6
16
20
QDG00
NOMESCO Finland
Debridement of bedsore of lower limb
25.1
7.6
10
*
I50.9
ICD-10 Finland
Heart failure, unspecified
1.9
7.6
103
550
-57
ICPC
Physical medicine/rehabilitation
8.9
7.5
15
17
JN1BG
NOMESCO Finland
MRI examination of upper part of abodmen with high intensity magnet
5.4
7.5
21
39
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.2
7.5
73
341
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.2
7.5
77
366
-48
ICPC
Clarification/discussion RFE/demand
3.0
7.5
41
140
L81
ICPC
Injury musculoskeletal NOS
3.5
7.5
33
96
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
3.5
7.5
33
96
T36
ICD-10 Finland
Poisoning by systemic antibiotics
2.4
7.5
59
249
NH1CF
NOMESCO Finland
Ankle and foot extensive MRI examination with median intensity magnet
80.5
7.4
8
*
J02AC01
ATC
fluconazole; systemic
1.4
7.4
588
4840
NF1DA
NOMESCO Finland
X-ray of hips
3.3
7.4
35
108
ZYC01
SPAT
NA
0.2
7.4
9
388
P01AB01
ATC
metronidazole; oral, rectal
1.4
7.3
531
4298
WX1DG
NOMESCO Finland
Very extensive total body MRI with high intensity magnet
+∞
7.3
7
*
QDE99
NOMESCO Finland
Other excision or repair of lesion of skin of lower limb
6.9
7.3
17
25
Z75.1
ICD-10 Finland
Person awaiting admission to adequate facility elsewhere
3.9
7.3
28
73
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.8
7.3
118
674
N06AB05
ATC
paroxetine; oral
2.0
7.2
85
432
M01AB51
ATC
indometacin, combinations; oral, rectal
3.2
7.2
35
110
Z02.7
ICD-10 Finland
Issue of medical certificate
2.2
7.2
70
325
D70.82
ICD-10 Finland
Drug-induced neutropenia
4.1
7.2
26
64
H26.3
ICD-10 Finland
Drug-induced cataract
7.3
7.2
16
22
L08
ICPC
Shoulder symptom/complaint
1.5
7.1
221
1512
QDG10
NOMESCO Finland
Excision and repair of bedsore of lower limb
30.2
7.1
9
*
QDD20
NOMESCO Finland
Excision of burn of lower limb and coverage
20.1
7.1
10
5
M86.6
ICD-10 Finland
Other chronic osteomyelitis
20.1
7.1
10
5
WB133
NOMESCO Finland
Very demanding adjuvant cytostatic therapy
8.0
7.1
15
19
NB6AA
NOMESCO Finland
Humerus X-ray examination
3.6
7.1
30
85
130
Kela drug reimbursment
Malignant tumour
2.1
7.1
74
355
L08
ICD-10 Finland
Other local infections of skin and subcutaneous tissue
4.1
7.1
26
65
C50.22
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,lobular tumor
6.1
7.1
18
30
QBE00
NOMESCO Finland
Excision of loose skin or fold of skin from trunk
8.8
7.0
14
16
EB1AD
NOMESCO Finland
Cone beam CT of teeth and jaws (one quarter)
8.8
7.0
14
16
L01XE33
ATC
[U] palbociclib; oral
10.1
7.0
13
13
1501
Kela drug reimbursment
Palbociclib
7.0
7.0
16
23
L16
ICPC
Ankle symptom/complaint
1.7
6.9
129
768
N06AB10
ATC
escitalopram; oral
1.5
6.9
249
1762
L02
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle
2.5
6.9
50
203
PJA10
NOMESCO Finland
Exploration of lymph nodes
4.3
6.9
24
57
E66.8
ICD-10 Finland
Other obesity
2.1
6.9
71
341
J01CE02
ATC
phenoxymethylpenicillin; oral
1.4
6.9
871
7687
NH1DG
NOMESCO Finland
Ankle and foot very extensive MRI examination with high intensity magnet
13.8
6.9
11
8
QAJ10
NOMESCO Finland
Browlift
13.8
6.9
11
8
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
3.1
6.9
36
120
XCW99
NOMESCO Finland
Other investigative procedure of eye
0.4
6.9
33
749
A06AD11
ATC
lactulose; oral
1.7
6.9
145
898
W19
ICD-10 Finland
Unspecified fall
1.9
6.9
100
551
SPAT1255
SPAT
Intravenous administration of medicine
2.1
6.9
73
356
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.7
6.9
151
945
T88.8
ICD-10 Finland
Other specified complications of surgical and medical care, not elsewhere classified
8.3
6.8
14
17
EP1BG
NOMESCO Finland
MRI examination of soft tissue of neck with high intesity magnet
11.0
6.8
12
11
R01AD08
ATC
fluticasone; nasal
1.4
6.8
368
2825
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
2.6
6.8
48
192
TNG10
NOMESCO Finland
Puncture of knee
4.5
6.8
22
49
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
2.2
6.8
63
290
XQ800
NOMESCO Finland
Prick test
1.9
6.8
103
576
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
6.1
6.8
17
28
XX6KT
NOMESCO Finland
Other sclerotherapy
40.2
6.8
8
*
Z53.2
ICD-10 Finland
Procedure not carried out because of patient's decision for other and unspecified reasons
40.2
6.8
8
*
NB1CG
NOMESCO Finland
Shoulder and humerus extensive MRI examination with high intensity magnet
3.2
6.8
33
105
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.0
6.8
81
415
V49.9
ICD-10 Finland
Car occupant [any] injured in unspecified traffic accident
2.6
6.7
45
175
L03
ICPC
Low back symptom/complaint
1.5
6.7
291
2136
ULC02
NOMESCO Finland
Hysteroscopy
2.0
6.7
87
459
M05BB03
ATC
alendronic acid and colecalciferol; oral
3.2
6.7
32
100
8500/3-C50.8
ICD-O-3
Infiltrating duct carcinoma, NOS, of overlapping lesion of breast
7.2
6.7
15
21
S01BC05
ATC
ketorolac; ophthalmic
2.6
6.7
45
176
R78
ICPC
Acute bronchitis/bronchiolitis
3.2
6.7
33
106
C44.42
ICD-10 Finland
Spinocellular carcinoma of the skin of the scalp and neck
22.6
6.7
9
*
N64.2
ICD-10 Finland
Atrophy of breast
22.6
6.7
9
*
N06AA10
ATC
nortriptyline; systemic
3.1
6.6
34
112
NGF25
NOMESCO Finland
Operation for osteochondritis of knee, arthroscopic
2.0
6.6
82
424
H02AB06
ATC
prednisolone; systemic
1.4
6.6
566
4688
R06AE07
ATC
cetirizine; oral
1.4
6.6
555
4582
R19.8
ICD-10 Finland
Other specified symptoms and signs involving the digestive system and abdomen
4.2
6.6
23
55
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
4.2
6.6
23
55
NC1BA
NOMESCO Finland
Elbow extensive X-ray examination
5.9
6.6
17
29
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.5
6.6
47
189
DFF00
NOMESCO Finland
Pure tone audiometry
1.9
6.6
86
455
S21
ICPC
Skin texture symptom/complaint
1.7
6.6
139
861
QCD20
NOMESCO Finland
Excision of burn of upper limb and coverage
12.3
6.6
11
9
WB223
NOMESCO Finland
Demanding adjuvant hormone therapy of malignancy
12.3
6.6
11
9
Z94.0
ICD-10 Finland
Kidney transplant status
12.3
6.6
11
9
L29
ICPC
Musculoskeletal sympt/complt other
1.9
6.6
88
471
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
3.1
6.6
34
113
SPAT1104
SPAT
Monitoring of emergency patient
2.0
6.6
80
414
C43.50
ICD-10 Finland
Malignant melanoma of the torso without histology
8.7
6.6
13
15
17402
ICD-8 Finland
Malignant neoplasm of breast, Glandulae
10.1
6.5
12
12
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
2.7
6.5
42
158
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
2.1
6.5
70
342
A04
ICPC
Weakness/tiredness general
1.7
6.5
141
879
NC2AA
NOMESCO Finland
Forearm X-ray examination
4.5
6.5
21
47
F32
ICD-10 Finland
Depressive episode
2.1
6.4
68
332
M86.4
ICD-10 Finland
Chronic osteomyelitis with draining sinus
70.1
6.4
7
*
ZZA40
NOMESCO Finland
Graft of synthetic skin substitute
70.1
6.4
7
*
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
70.1
6.4
7
*
Z51.6
ICD-10 Finland
Desensitization to allergens
70.1
6.4
7
*
GD2SN
NOMESCO Finland
Lung ventilation SPECT
7.4
6.4
14
19
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
7.4
6.4
14
19
R4120
NOMESCO Finland
Occupational therapy
2.1
6.4
68
333
QWH99
NOMESCO Finland
Other reoperation in surgery of skin
14.4
6.4
10
7
C50.5
ICD-10 Finland
Malignant neoplasm: Lower-outer quadrant of breast
14.4
6.4
10
7
QBG30
NOMESCO Finland
Delayed skin closure of surgical wound in trunk
14.4
6.4
10
7
NFR30
NOMESCO Finland
Extended excision of soft tissue tumour of hip or thigh
14.4
6.4
10
7
L91.8
ICD-10 Finland
Other hypertrophic disorders of skin
14.4
6.4
10
7
S11
ICPC
Skin infection post-traumatic
4.4
6.4
21
48
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
6.6
6.3
15
23
E9399
ICD-8 Finland
Complications and failures arising in connection with medical procedures (excluding subsequent adverse effects).
6.6
6.3
15
23
A06AH03
ATC
naloxegol; oral
8.2
6.3
13
16
DFF15
NOMESCO Finland
Speech audiometry
2.9
6.3
36
125
SHA01
NOMESCO Finland
Correction of physiology of bite - simple therapy visit
1.6
6.3
144
910
D07AC13
ATC
mometasone; topical
1.4
6.3
349
2683
QXB10
NOMESCO Finland
Exchange of dressing for large skin wound, unspecified location
11.1
6.3
11
10
QB9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in torso, unspecified
9.3
6.3
12
13
9703
FHL
Breast resection
4.6
6.3
20
44
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
2.8
6.3
38
140
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
18.1
6.3
9
5
N18.0
ICD-10 Finland
End-stage renal disease
18.1
6.3
9
5
Z51.4
ICD-10 Finland
Preparatory care for subsequent treatment, not elsewhere classified
+∞
6.3
6
*
WC205
NOMESCO Finland
Simple therapy of local tumor recidive with hormone
+∞
6.3
6
*
WZC30
NOMESCO Finland
Teaching
1.6
6.2
147
940
ZSP00
NOMESCO Finland
Procedure related to previous procedure classified in chapter P
26.8
6.2
8
*
GA1CG
NOMESCO Finland
Extensive MRI of chest
26.8
6.2
8
*
9722
FHL
Reduction plastic and possible mamilla transposition
7.1
6.2
14
20
G47.3
ICD-10 Finland
Sleep apnoea
1.5
6.2
228
1618
L08.9
ICD-10 Finland
Local infection of skin and subcutaneous tissue, unspecified
2.8
6.2
37
135
SPAT1053
SPAT
Memory test
1.6
6.2
141
892
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.6
6.1
174
1166
C44.11
ICD-10 Finland
Basocellular carcinoma of the skin of the eyelids including the corner of the eye
4.7
6.1
19
41
Y84
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
4.7
6.1
19
41
NHS99
NOMESCO Finland
Other operation for infection of tendon, joint or bone of ankle or foot
12.6
6.1
10
8
C43.7
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of lower limb, including hip
12.6
6.1
10
8
N61
ICD-10 Finland
Inflammatory disorders of breast
2.7
6.0
37
138
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
685
1606
7.05
304.10
4.7
4.3
%
32.6
33.0
0.38
430
1079
(3019225) pH of Specimen
592
1222
7.38
298.11
5.0
3.3
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
740
2845
4.18
162.06
2.7
2.0
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
238
385
7.17
144.93
4.4
2.9
mmol/l
24.8
25.0
0.32
214
347
(3022313) Gas panel - Capillary blood
241
424
6.59
135.00
4.2
2.8
—
—
—
0
0
(3013512) EKG study
779
3488
3.59
128.55
4.7
3.3
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
799
3737
3.46
120.95
2.9
2.1
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
251
580
5.00
103.39
4.4
2.8
kpa
5.2
5.1
0.41
229
539
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
243
554
5.05
101.64
4.4
2.8
mmol/l
1.3
1.7
1.03
193
409
(3002385) Erythrocyte distribution width [Ratio]
633
10403
0.32
101.36
17.3
13.6
%
13.7
13.6
0.57
625
10161
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
200
418
5.37
92.16
2.0
1.7
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
184
378
5.41
86.28
1.9
1.6
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
419
1590
3.28
84.33
6.2
6.1
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
893
5282
2.73
76.29
6.2
4.7
mmol/l
1.2
1.2
3.10
738
4740
(40768804) Tissue Pathology biopsy report
879
5358
2.57
67.38
2.8
2.0
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
898
5637
2.50
62.94
3.7
3.6
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
79
103
8.04
57.34
2.4
3.6
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
923
6159
2.31
52.07
9.0
5.2
umol/l
10.5
10.6
0.08
867
5807
(3044889) 12 lead EKG panel
573
8708
0.44
49.02
3.3
3.4
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
870
5770
2.22
48.33
8.1
5.2
mmol/l
1.2
1.2
1.20
752
4821
(3032080) INR in Blood by Coagulation assay
698
4255
2.21
47.76
5.2
7.2
inr
1.1
1.2
1.32
40
1255
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1226
9504
2.65
45.70
10.9
6.4
u/l
79.9
75.3
2.25
1127
8892
(3017354) Segmented neutrophils/100 leukocytes in Blood
62
88
7.31
41.74
2.7
3.1
%
59.7
52.3
1.16
49
60
(3017732) Neutrophils [#/volume] in Blood
225
868
2.88
41.57
2.7
2.8
e9/l
4.2
4.1
0.39
125
693
(4035726)
255
1055
2.71
41.21
1.5
1.3
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
389
1991
2.29
39.50
1.8
1.7
nmol/l
961.4
1211.7
6.73
244
1493
(3042936) Bacteria identified in Isolate by Culture
319
1502
2.43
39.20
2.6
1.8
—
—
—
0
0
(4146454)
71
124
5.96
39.20
2.6
2.7
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
474
2652
2.16
38.45
3.4
3.7
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
674
4309
2.03
38.07
4.1
3.1
ng/l
37.6
41.0
0.11
488
2714
(3021589) Normoblasts [#/volume] in Blood
281
5302
0.42
37.71
7.5
8.2
e9/l
0.0
0.0
0.72
207
4318
(3025468) Yersinia sp identified in Specimen by Organism specific culture
72
135
5.55
36.89
1.6
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
72
135
5.55
36.89
1.6
1.3
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
618
3863
2.03
36.86
6.2
5.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
72
136
5.51
36.59
1.6
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
72
138
5.43
36.02
1.6
1.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
71
135
5.47
35.83
1.6
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
72
139
5.39
35.73
1.6
1.3
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
233
1027
2.50
32.61
2.4
2.1
g/l
0.2
0.2
2.08
219
969
(3014271) Vancomycin [Susceptibility]
39
43
9.29
32.22
3.0
2.8
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
492
2958
1.99
31.70
3.2
2.5
ng/l
1671.2
858.6
2.30
370
2468
(3004616) Nuclear Ab [Presence] in Serum
72
155
4.83
31.54
1.4
1.3
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
260
1233
2.34
30.84
2.2
1.6
—
—
—
0
0
(40768793) Breast Pathology biopsy report
125
413
3.21
30.02
1.5
1.3
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
756
5314
1.86
29.70
2.5
2.2
nmol/l
79.1
78.6
0.20
590
4795
(3032057) Clostridioides difficile [Presence] in Stool
27
19
14.45
29.69
1.3
2.2
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
898
6678
1.87
29.30
4.4
3.9
mmol/l
6.6
6.6
0.04
839
6209
(3037121) Protein [Mass/volume] in Urine
112
351
3.37
29.29
3.6
2.8
g/l
0.3
0.2
0.86
42
124
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
67
145
4.79
29.16
1.9
2.1
mg/l
23.2
27.7
0.21
18
41
(3002256) Pathology report gross observation
314
1644
2.15
29.14
1.7
1.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
153
579
2.83
28.92
1.7
1.5
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1048
8228
1.93
28.42
4.4
2.9
u/l
54.6
42.1
2.70
938
7646
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
237
1123
2.32
27.99
3.7
3.7
ug/l
24.8
12.7
0.35
175
889
(3004809) Band form neutrophils/100 leukocytes in Blood
65
144
4.67
27.51
2.6
3.3
%
2.1
1.3
0.57
51
117
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
84
227
3.86
27.41
1.2
1.3
u/l
35.9
30.5
0.59
70
185
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
105
330
3.35
27.32
2.2
2.2
ug/l
195.7
420.7
0.84
92
303
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
691
4815
1.81
27.09
2.1
1.9
pmol/l
108.7
98.2
4.81
350
2352
(3019069) Monocytes/100 leukocytes in Blood
765
5543
1.78
25.87
6.4
5.8
%
8.1
8.3
1.11
676
5159
(3002030) Lymphocytes/100 leukocytes in Blood
782
5705
1.78
25.80
6.0
5.6
%
27.8
29.1
2.61
672
5276
(3006504) Eosinophils/100 leukocytes in Blood
757
5512
1.76
24.77
5.7
5.5
%
2.9
2.8
0.23
663
5097
(3013650) Neutrophils [#/volume] in Blood by Automated count
910
7009
1.77
24.22
10.1
7.9
e9/l
3.7
3.9
2.22
819
6088
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
551
3684
1.79
24.04
2.8
2.3
u/l
55.6
57.1
0.30
485
3356
(3018010) Neutrophils/100 leukocytes in Blood
762
5645
1.72
22.70
5.6
5.4
%
57.5
56.3
2.03
658
5247
(3015377) Calcium [Moles/volume] in Serum or Plasma
602
4185
1.74
22.56
4.3
2.9
mmol/l
2.4
2.4
1.15
410
3671
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
48
98
5.03
22.37
1.4
1.7
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
44
84
5.37
22.10
2.9
2.0
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
288
1611
1.98
21.74
2.0
1.7
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
48
107
4.60
20.18
1.4
1.7
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
40
77
5.31
19.92
1.2
1.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
203
1030
2.12
19.91
1.2
1.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
95
340
2.92
19.81
1.4
1.3
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
806
6196
1.66
19.79
5.6
5.6
e9/l
0.2
0.2
0.45
704
5398
(1617658) Protocol used for examination of sentinel lymph nodes
56
145
3.97
19.41
1.1
1.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
299
4699
0.54
19.21
2.1
2.7
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
711
5322
1.64
19.18
5.9
5.6
%
0.7
0.7
0.03
615
4924
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
208
1080
2.08
19.16
3.8
4.0
u/l
231.0
230.4
0.02
176
1019
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
75
239
3.25
19.08
1.7
1.3
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
29
43
6.86
18.73
2.4
2.6
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
27
39
7.03
17.85
1.3
1.6
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
27
39
7.03
17.85
1.3
1.6
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
1011
8351
1.66
17.71
5.0
4.0
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
1105
9346
1.71
17.63
5.1
4.0
mm/h
13.8
11.4
4.68
954
8628
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
27
40
6.86
17.44
1.7
1.1
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
27
40
6.86
17.44
1.7
1.1
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
423
2835
1.69
17.10
2.4
2.1
mg/l
3.4
3.0
2.74
331
2391
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
493
3451
1.64
16.78
2.2
2.0
u/l
137.0
210.4
1.62
455
3218
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1331
11965
2.07
16.65
13.8
10.3
ml/min/173m2
81.9
82.3
0.29
1163
9739
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
26
39
6.77
16.61
1.3
1.6
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
221
1231
1.93
16.58
28.0
22.6
inr
1.9
1.3
1.01
13
156
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
20
24
8.43
15.40
2.1
2.5
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
160
817
2.07
15.30
2.4
2.9
u/ml
36.3
40.0
0.15
155
789
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
316
4676
0.59
15.29
3.4
3.6
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
27
46
5.96
15.28
1.7
1.1
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
190
3235
0.53
15.18
3.0
2.8
e6/l
72.6
85.3
0.10
140
2401
(3041096) Erythrocytes [Presence] in Urine by Automated
188
3209
0.53
15.14
2.5
3.0
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
27
47
5.83
14.95
1.7
1.1
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
757
5974
1.54
14.87
5.6
5.4
e9/l
0.0
0.0
0.72
678
5135
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
27
48
5.71
14.64
1.3
1.5
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
27
48
5.71
14.64
1.3
1.5
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
27
48
5.71
14.64
1.3
1.5
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
27
48
5.71
14.64
1.3
1.5
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
84
331
2.63
14.61
2.2
1.8
ug/l
0.9
2.2
1.30
61
290
(40761536) Microorganisms panel - Urine sediment
26
1064
0.23
14.61
3.5
3.6
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
771
6128
1.54
14.52
5.6
5.4
e9/l
1.8
1.9
1.87
678
5364
(3001604) Monocytes [#/volume] in Blood
752
5947
1.53
14.48
5.6
5.4
e9/l
0.6
0.6
0.01
675
5113
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
130
627
2.18
14.40
1.5
1.5
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
14
11
12.84
14.27
1.1
1.5
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
40
103
3.96
14.01
1.2
1.2
—
76.6
—
0
8
(4010399)
165
882
1.98
13.87
1.4
1.4
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
453
6042
0.64
13.57
4.4
4.6
estimate
0.0
0.0
0.50
27
1068
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
75
290
2.67
13.56
2.5
2.8
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
55
180
3.13
13.44
1.5
1.6
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
156
828
1.99
13.38
2.4
2.5
e9/l
69.6
70.7
0.17
133
612
(3051593) INR in Capillary blood by Coagulation assay
24
42
5.79
13.22
1.1
12.4
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
264
1661
1.72
13.09
3.0
2.7
mmol/l
0.8
0.8
0.15
225
1553
(40768443) Skin Pathology biopsy report
112
536
2.18
12.65
1.3
1.2
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
185
3008
0.56
12.19
2.7
2.7
e6/l
0.2
0.4
1.34
136
2202
(3021960) Folate [Moles/volume] in Serum or Plasma
376
2634
1.57
12.06
1.6
1.5
nmol/l
22.2
21.6
0.25
248
2230
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
15
17
8.90
12.01
1.0
1.1
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
1385
12881
2.09
11.96
19.1
12.5
mmol/l
139.8
139.8
0.23
1329
12535
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1353
12488
1.92
11.87
18.1
11.1
mg/l
21.0
21.6
0.31
1142
9567
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
34
88
3.93
11.85
1.4
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
34
88
3.93
11.85
1.4
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
34
88
3.93
11.85
1.4
1.5
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1304
11904
1.77
11.84
6.1
5.0
mu/l
1.9
2.1
0.62
1097
10937
(3035350) Ketones [Presence] in Urine by Test strip
459
5992
0.66
11.79
3.2
3.5
estimate
0.0
0.0
0.50
26
1061
(3024561) Albumin [Mass/volume] in Serum or Plasma
629
4932
1.48
11.77
4.3
3.8
g/l
35.3
36.2
3.61
549
4588
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
14
15
9.41
11.66
1.0
1.1
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
272
3962
0.62
11.53
3.2
3.2
e6/l
59.3
108.8
1.40
166
2642
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
84
372
2.33
11.43
1.1
1.1
u/ml
4.5
6.1
—
6
57
(3023103) Potassium [Moles/volume] in Serum or Plasma
1386
12924
2.06
11.40
19.3
12.6
mmol/l
4.0
3.9
2.56
1320
12561
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
13
13
10.08
11.35
1.2
1.3
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
54
194
2.85
11.25
2.9
3.1
u/ml
220.0
80.1
0.49
49
182
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
24
49
4.96
11.23
1.7
1.6
—
—
—
0
0
(3018418) pH of Serum or Plasma
229
3457
0.60
11.20
5.4
3.1
ph
7.4
7.4
0.06
17
640
(3009261) Glucose [Presence] in Urine by Test strip
474
6103
0.67
11.11
3.3
3.5
estimate
0.0
0.0
1.08
25
1043
(3003458) Phosphate [Moles/volume] in Serum or Plasma
211
1304
1.72
11.06
5.8
3.5
mmol/l
1.1
1.0
2.04
187
1192
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
129
694
1.94
10.62
1.7
1.5
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
74
322
2.37
10.49
1.4
1.4
ug/g
300.0
315.1
0.23
39
177
(36304419) Bacteria [Presence] in Urine
191
2965
0.59
10.31
2.7
2.6
—
—
—
0
0
(4015189)
16
24
6.73
10.19
1.6
2.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
238
3491
0.62
10.14
1.6
1.6
mmol/l
1.3
1.3
0.04
217
2908
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
32
89
3.65
10.11
1.1
1.1
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
83
386
2.22
10.09
1.5
1.7
g/l
1.7
1.5
1.10
66
336
(3045424) Erythrocytes [Presence] in Urine
53
202
2.68
9.91
1.2
1.5
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
181
1106
1.72
9.85
2.5
2.4
%
1.9
1.8
0.77
133
980
(40760892) CBC W Ordered Manual Differential panel - Blood
178
2776
0.59
9.71
3.6
4.4
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
31
87
3.62
9.68
1.1
1.3
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
136
2275
0.56
9.65
2.7
2.3
e6/l
5.9
6.9
0.54
121
1978
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
40
136
2.99
9.23
1.1
1.5
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
35
110
3.23
9.21
1.3
1.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
1394
13147
1.95
9.20
18.7
10.8
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
393
2924
1.47
9.12
1.3
1.3
u/ml
1.7
1.5
0.07
56
786
(3029937) Albumin [Presence] in Urine by Test strip
227
3293
0.63
9.03
3.5
3.9
estimate
0.0
0.0
1.08
27
1059
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1414
13412
2.09
9.01
14.5
9.4
u/l
26.3
24.6
2.13
1308
12938
(40768797) Stomach Pathology biopsy report
261
1798
1.55
8.74
1.3
1.2
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
663
5466
1.38
8.48
2.8
2.6
ug/l
124.3
101.7
2.30
569
5078
(3004789) Transferrin [Mass/volume] in Serum or Plasma
221
1475
1.59
8.48
2.3
1.9
g/l
2.4
2.4
0.06
185
1357
(3023183) Ammonium ion [Moles/volume] in Plasma
48
191
2.56
8.29
2.3
2.8
umol/l
29.7
37.0
1.25
38
166
(3026782) Osmolality of Urine
125
2058
0.57
8.27
2.2
2.3
mosm/kgh2o
453.8
539.3
5.26
103
1726
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
146
882
1.73
8.26
3.9
2.6
ng/l
70.4
73.3
0.20
112
764
(3005570) Glucose [Moles/volume] in Urine
33
108
3.10
8.15
2.3
2.1
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
77
380
2.08
8.10
1.7
1.4
pmol/l
71.6
170.6
1.46
77
373
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
121
1998
0.57
8.08
3.8
3.1
ng/l
80.4
359.1
4.16
89
1428
(3007164) IgA [Mass/volume] in Serum or Plasma
334
2462
1.46
8.00
1.5
1.4
g/l
2.2
2.3
0.28
168
1504
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
102
562
1.87
7.84
1.3
1.4
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
59
267
2.26
7.71
1.8
1.6
e6/l
20754.1
9908.8
0.71
45
207
(3021788) Differential panel - Synovial fluid
47
192
2.50
7.71
1.7
1.6
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
55
1143
0.46
7.61
2.4
2.8
—
—
—
0
0
(3022145) Colonoscopy Study observation
212
1436
1.56
7.60
1.2
1.3
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
10
12
8.38
7.58
2.2
2.3
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
25
72
3.51
7.56
1.4
1.4
—
836.3
—
0
8
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
80
415
1.98
7.36
1.4
2.1
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
360
2732
1.42
7.29
1.7
1.7
mg/l
0.9
1.0
0.47
261
2075
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
15
30
5.04
7.19
1.2
1.0
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
27
85
3.22
7.13
1.0
1.2
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
10
13
7.74
7.12
2.2
2.2
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
14
27
5.22
6.97
1.1
1.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
155
997
1.62
6.91
3.6
3.3
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
16
36
4.48
6.71
1.4
1.4
g/l
41.6
40.2
—
8
20
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
105
614
1.76
6.68
2.4
2.3
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
129
801
1.67
6.61
1.4
1.3
au/ml
67.0
40.7
—
9
43
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
89
499
1.83
6.52
2.5
2.0
u/l
42.3
39.5
0.71
76
450
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
197
1358
1.52
6.50
2.5
1.9
%
21.2
23.7
1.80
167
1154
(3022948) Iron [Moles/volume] in Serum or Plasma
230
1644
1.47
6.35
2.4
1.9
umol/l
12.3
13.9
2.42
200
1503
(3006462) Nitrate [Presence] in Urine
20
56
3.61
6.32
6.2
2.9
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
32
120
2.70
6.27
1.1
1.2
u/l
48.6
52.9
—
7
81
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
13
26
5.04
6.23
1.2
1.1
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
40
169
2.40
6.16
1.4
1.6
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
220
1569
1.47
6.14
2.2
2.2
ug/g
131.4
112.3
0.62
154
1246
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
10
8
12.57
6.08
1.1
1.4
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
68
358
1.94
6.05
1.2
1.3
u/ml
7.2
2.4
—
5
42
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
68
363
1.92
5.82
1.2
1.3
u/ml
2.4
11.6
—
8
69
(3020491) Glucose [Moles/volume] in Blood
26
91
2.89
5.79
1.3
1.5
mmol/l
5.9
6.6
0.95
15
62
(3011397) Hemoglobin [Presence] in Urine by Test strip
213
2893
0.69
5.75
3.8
3.6
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
13
28
4.67
5.74
1.2
1.1
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
29
109
2.69
5.68
10.7
5.4
mg/l
12.9
11.4
1.20
23
100
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1286
12118
1.45
5.64
4.7
3.9
mmol/l
1.3
1.3
1.57
1069
11128
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
16
42
3.84
5.54
1.3
2.3
—
—
—
0
0
(3048879) Bone marrow aspiration report
12
25
4.83
5.50
1.3
1.8
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
204
1466
1.45
5.46
1.5
1.3
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
15
38
3.98
5.44
1.1
1.4
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
118
755
1.61
5.40
8.3
4.8
mmol/l
10.7
8.4
2.32
111
708
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
9
8
11.31
5.29
1.2
1.3
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
12
26
4.64
5.26
1.2
1.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
48
235
2.08
5.25
1.4
1.4
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
134
890
1.56
5.24
2.8
2.4
au/ml
21.4
20.0
0.05
12
50
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
107
1641
0.63
5.22
2.2
2.5
e6/l
5.1
3.6
0.51
50
813
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
16
44
3.67
5.21
1.0
1.3
—
—
—
0
0
(4211845)
20
64
3.15
5.20
6.2
2.7
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
173
1219
1.47
5.13
1.5
1.4
—
—
—
0
0
(4024509)
27
104
2.63
5.07
1.9
1.5
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
16
45
3.58
5.05
1.1
1.2
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
9
9
10.05
5.03
1.0
1.0
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
62
338
1.87
5.02
1.3
1.3
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
11
23
4.81
5.01
1.1
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
23
82
2.83
4.99
1.1
1.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
50
254
2.00
4.97
2.1
2.8
u/ml
0.3
0.4
0.72
32
135
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1109
10268
1.31
4.93
4.9
4.2
pmol/l
14.9
14.7
1.69
926
9379
(3019150) Specific gravity of Urine by Refractometry
200
2679
0.71
4.91
4.1
4.0
kg/l
1.0
1.0
0.51
44
386
(3003327) Ova and parasites identified in Stool by Light microscopy
71
409
1.77
4.82
1.9
1.8
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
23
84
2.77
4.79
1.1
1.2
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
8
7
11.48
4.78
1.4
1.3
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
59
322
1.87
4.77
1.1
1.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
25
96
2.63
4.74
1.2
1.1
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
12
29
4.16
4.63
1.1
1.2
—
—
—
0
0
(4034850)
16
447
0.35
4.57
12.0
9.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
54
291
1.89
4.55
1.2
1.1
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
36
167
2.18
4.55
4.2
4.5
iu/ml
6977.6
535.9
—
7
17
(1761482) Bacteria [#/volume] in Urine by Culture
6
243
0.24
4.50
1.8
3.3
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
29
124
2.37
4.43
1.1
1.1
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
33
151
2.21
4.32
1.8
1.6
%
57.0
60.0
0.16
23
99
(3036481) Cortisol [Moles/volume] in Serum or Plasma
153
1089
1.45
4.32
2.4
2.0
nmol/l
382.1
371.0
0.28
128
987
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
58
328
1.80
4.23
1.7
1.3
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
1438
13999
1.81
4.21
28.1
17.2
e9/l
6.6
6.5
0.60
1398
13607
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
11
27
4.10
4.16
1.0
1.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
28
123
2.30
4.05
2.4
2.5
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
369
3041
1.28
4.05
3.1
2.2
umol/l
335.1
5442.8
9.54
287
2631
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
11
28
3.95
3.98
1.1
1.1
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
131
1823
0.69
3.96
2.2
2.4
e6/l
1.4
1.1
0.40
73
995
(3007461) Platelets [#/volume] in Blood
1436
13990
1.76
3.96
28.0
17.2
e9/l
260.7
259.0
0.42
1396
13638
(3024731) MCV [Entitic volume]
1436
13993
1.75
3.91
27.9
17.1
fl
91.1
91.0
0.66
1402
13801
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
47
256
1.86
3.88
1.5
1.2
—
—
—
0
0
(3035941) MCH [Entitic mass]
1436
13996
1.74
3.87
27.8
17.1
pg
30.2
30.2
0.49
1402
13803
(3026361) Erythrocytes [#/volume] in Blood
1436
13997
1.74
3.85
28.0
17.2
e12/l
4.4
4.5
12.72
1396
13604
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
43
228
1.91
3.85
1.4
1.6
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
50
279
1.82
3.83
1.1
1.2
u/l
19.1
13.2
1.31
38
221
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
41
742
0.54
3.81
1.9
2.5
ng/l
101.5
167.8
1.65
35
667
(3045414) Leukocytes [Presence] in Urine
84
542
1.58
3.79
1.4
1.8
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
1436
14002
1.73
3.78
28.1
17.3
g/l
131.1
134.4
16.95
1402
13811
(3028026) IgM [Mass/volume] in Serum or Plasma
100
673
1.52
3.75
1.7
1.7
g/l
1.1
1.4
2.06
87
613
(3003694) ABO and Rh group [Type] in Blood
270
3330
0.77
3.71
1.4
1.4
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
10
25
4.02
3.70
1.0
1.0
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
0
94
0.00
3.68
0.0
2.7
—
12.8
—
0
63
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1291
12346
1.35
3.67
5.5
4.4
mmol/l
5.9
5.8
0.15
1057
11296
(3000330) Specific gravity of Urine by Test strip
25
524
0.47
3.64
1.9
2.7
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
54
315
1.74
3.59
1.2
1.6
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
17
409
0.41
3.54
2.0
1.9
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1218
11569
1.29
3.53
6.7
5.4
mmol/mol
39.6
39.3
0.42
1003
10695
(3019174) dRVVT (LA screen)
8
13
6.18
3.50
1.0
1.2
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
25
112
2.25
3.49
1.1
1.1
nmol/l
447.2
386.9
0.87
25
103
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
20
81
2.49
3.47
1.3
1.6
u/ml
27.6
19.2
—
5
14
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
101
694
1.49
3.45
1.1
1.0
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
16
58
2.78
3.42
1.2
1.2
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
25
113
2.23
3.42
1.4
1.5
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
225
1775
1.32
3.40
1.5
1.3
titre
481.4
570.2
0.37
59
384
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
41
224
1.85
3.39
1.4
1.6
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
117
833
1.44
3.34
2.5
2.6
g/l
10.1
10.6
0.59
105
756
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
8
238
0.33
3.32
1.1
3.7
%
57.9
57.3
—
8
238
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
8
239
0.33
3.32
1.4
1.5
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
20
83
2.43
3.31
6.9
5.8
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
295
2423
1.27
3.27
1.4
1.3
iu/ml
54.4
34.4
0.74
80
786
(40763480) Human metapneumovirus Ag [Presence] in Specimen
6
7
8.60
3.26
1.0
1.0
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
16
60
2.68
3.23
1.3
1.5
nmol/l
1.3
1.2
—
8
46
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
8
15
5.36
3.19
1.0
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
8
15
5.36
3.19
1.0
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
8
15
5.36
3.19
1.0
1.0
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
104
734
1.45
3.12
2.5
2.2
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
5
182
0.27
3.11
1.2
2.4
mmol/l
1.0
1.5
—
5
173
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
33
173
1.93
3.11
1.2
1.1
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
8
231
0.34
3.05
1.1
3.5
e9/l
3.9
3.9
—
8
231
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
37
204
1.83
3.00
1.2
1.2
—
—
—
0
0
(3026726) Creatinine [Moles/volume] in Specimen
5
5
10.03
2.98
1.6
1.0
umol/l
156.6
259.4
—
5
5
(3020630) Protein [Mass/volume] in Serum or Plasma
117
856
1.40
2.90
3.2
2.5
g/l
67.2
67.1
0.05
95
775
(43055514) Macroprolactin [Presence] in Serum or Plasma
9
22
4.11
2.88
1.2
1.7
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
7
203
0.34
2.80
1.4
1.7
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
128
957
1.37
2.79
1.2
1.2
iu/ml
172.4
162.5
0.08
42
384
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
5
6
8.36
2.75
1.0
1.0
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
7
14
5.02
2.73
1.0
1.3
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
21
98
2.16
2.71
2.5
2.6
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
117
868
1.38
2.69
4.2
3.2
pmol/l
4.3
4.5
0.91
92
771
(3045683) HLA typing for celiac disease panel - Blood or Tissue
18
79
2.29
2.68
1.0
1.0
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
397
3438
1.21
2.67
3.7
3.1
mg/l
60.6
287.5
2.76
206
2032
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
276
2309
1.24
2.60
1.4
1.3
u/ml
19.8
11.4
0.55
67
923
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
34
192
1.79
2.60
1.2
1.2
u/ml
4.6
4.8
0.02
14
76
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
8
20
4.02
2.57
1.0
1.2
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
23
114
2.03
2.57
1.3
2.1
umol/l
4.2
6.8
0.83
14
76
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
12
44
2.74
2.55
1.1
1.2
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
76
529
1.46
2.50
1.6
1.6
mg/l
3.4
3.9
0.13
64
377
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
114
853
1.36
2.50
2.2
2.2
ug/l
4.4
6.2
0.86
68
755
(3027456) Digoxin [Moles/volume] in Serum or Plasma
29
158
1.85
2.49
2.9
3.1
nmol/l
0.8
0.8
0.03
18
126
(3028308) Erythrocytes [#/volume] in Pleural fluid
18
82
2.21
2.48
1.3
1.3
e6/l
88078.8
174467.1
0.30
11
38
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
7
16
4.39
2.47
1.4
1.2
%
13.4
20.2
—
7
10
(3006922) Hepatitis E virus Ab [Presence] in Serum
15
63
2.40
2.46
1.1
1.1
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
411
3597
1.20
2.45
4.2
3.8
mg/mmol
9.3
7.0
0.54
204
2141
(4281824)
28
152
1.86
2.43
1.1
1.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
414
3629
1.20
2.42
3.6
3.0
mmol/l
7.1
7.1
0.04
288
3032
(40765096) Chromosome analysis panel by Banding
10
34
2.95
2.41
1.2
1.0
—
—
—
0
0
(40768441) Liver Pathology biopsy report
18
83
2.18
2.41
1.0
1.3
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
35
205
1.72
2.38
1.1
1.1
u/ml
3.6
2.7
0.21
11
94
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
201
1641
1.26
2.35
1.5
1.5
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1306
12651
1.26
2.31
5.0
4.4
mmol/l
4.9
4.8
0.88
1091
11767
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
9
28
3.23
2.31
1.1
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
14
59
2.39
2.29
1.1
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
14
59
2.39
2.29
1.1
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
23
120
1.93
2.26
1.3
1.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
864
8080
1.17
2.23
2.9
3.0
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
123
1575
0.76
2.23
4.0
4.6
%
20.4
21.2
0.26
76
787
(3035637) Corticotropin [Mass/volume] in Plasma
22
114
1.94
2.21
1.5
1.5
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
55
802
0.67
2.21
5.2
2.8
mmol/l
1.3
2.0
0.58
43
654
(3049717) Cytology report of Urine Cyto stain
54
361
1.51
2.20
2.8
2.5
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1296
12557
1.25
2.19
5.4
4.3
mmol/l
1.6
1.5
1.15
1083
11605
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
25
136
1.85
2.18
1.0
1.1
%
92.4
93.5
0.07
25
125
(3023199) Leukocytes [#/volume] in Pleural fluid
19
94
2.03
2.16
1.3
1.3
e6/l
1150.7
2213.4
1.13
14
58
(3028626) Oxygen [Partial pressure] in Capillary blood
6
165
0.36
2.15
4.8
2.3
kpa
8.1
8.1
—
6
150
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
14
4.30
2.15
1.0
1.3
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
7
19
3.70
2.15
1.0
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
30
496
0.60
2.12
1.3
1.5
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
23
123
1.88
2.12
1.9
1.3
e6/l
197925.9
134481.6
0.14
18
82
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
19
95
2.01
2.11
1.3
1.7
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
8
25
3.21
2.09
1.3
1.1
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
30
494
0.60
2.09
10.5
9.8
—
—
—
0
0
(4306422)
31
183
1.71
2.09
1.1
1.2
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
16
75
2.15
2.08
1.6
1.5
—
—
—
0
0
(3012565) Volume of 24 hour Urine
0
56
0.00
2.06
0.0
2.5
—
1994.5
—
0
50
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
6
15
4.01
2.04
1.0
1.1
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
8
26
3.09
2.01
1.0
1.0
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
21
111
1.90
2.01
1.3
1.2
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
14
63
2.23
2.01
1.2
1.1
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
30
178
1.70
1.99
1.0
1.1
%
116.9
117.4
0.02
30
157
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
138
1101
1.28
1.97
2.1
1.8
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
11
243
0.45
1.97
1.5
1.4
e6/l
0.4
48.6
—
5
183
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
11
243
0.45
1.97
1.5
1.5
e6/l
51.2
2075.5
—
6
191
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
295
2556
1.19
1.95
1.4
1.6
pmol/l
489.6
38588666.5
2.89
213
2125
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
6
16
3.76
1.93
1.0
1.2
ug/l
64.3
5.2
—
6
5
(3025941) Bacteria identified in Stool by Culture
90
680
1.34
1.91
1.3
1.2
—
—
—
0
0
(4094501)
19
344
0.55
1.90
1.1
1.1
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
85
1117
0.75
1.88
1.7
1.6
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
15
72
2.09
1.86
2.1
2.0
%
44.0
41.6
—
7
9
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
43
633
0.67
1.85
1.2
1.4
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
43
286
1.52
1.83
4.1
3.3
mg/l
33.6
57.8
0.89
38
236
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
14
66
2.13
1.82
1.2
1.2
—
—
—
0
0
(4268621)
23
130
1.78
1.82
2.1
2.3
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
331
2914
1.17
1.81
4.0
3.3
%
98.7
94.4
2.38
326
2831
(3012544) pH of Venous blood
60
827
0.71
1.81
5.0
2.8
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
43
287
1.51
1.81
4.1
3.3
mg/l
30.9
51.4
0.50
38
238
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
71
522
1.38
1.80
1.5
1.6
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
7
23
3.05
1.80
1.4
1.5
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
27
437
0.61
1.79
3.2
2.4
%
1.1
1.2
0.15
27
431
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
17
88
1.94
1.75
1.0
1.0
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
164
1357
1.23
1.74
1.8
1.7
%
1.4
1.4
0.51
135
1191
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
9
192
0.47
1.73
1.8
1.4
—
—
—
0
0
(40758558) Short blood count panel - Blood
346
3074
1.16
1.68
9.6
5.6
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
21
119
1.78
1.66
1.3
1.1
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
6
19
3.17
1.66
1.0
1.1
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
17
90
1.90
1.65
1.2
1.3
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
5
132
0.38
1.62
5.4
2.3
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
15
77
1.96
1.59
1.4
1.5
promille
1.6
1.2
0.40
15
59
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
148
1225
1.23
1.58
2.3
1.9
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
30
192
1.57
1.55
1.0
1.1
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
15
78
1.93
1.54
1.3
1.3
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
8
33
2.43
1.54
1.6
2.1
ug/l
60.3
52.1
—
8
33
(3004451) EKG impression Narrative
0
43
0.00
1.52
0.0
1.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
9
183
0.49
1.51
1.1
1.7
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
34
226
1.52
1.50
1.4
1.4
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
14
72
1.95
1.49
1.0
1.0
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
23
139
1.66
1.48
6.7
4.0
u/ml
379.2
56.8
—
8
41
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
25
155
1.62
1.47
1.2
1.1
u/ml
217.1
243.6
—
10
91
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
84
1062
0.78
1.44
2.9
2.1
u/l
29.8
36.4
0.90
75
907
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
5
16
3.13
1.44
1.6
1.4
ng/l
40.0
91.1
—
5
16
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
351
3881
0.87
1.41
2.5
2.9
u/l
31.6
31.0
0.20
320
3708
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
34
230
1.49
1.39
1.4
1.4
nmol/l
0.3
0.4
0.12
23
172
(3021879) Hepatitis B virus core Ab [Presence] in Serum
99
797
1.26
1.38
1.3
1.4
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
27
174
1.56
1.37
1.3
1.2
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
84
664
1.28
1.36
5.7
8.7
%
95.1
93.9
1.15
84
659
(3016650) Hepatitis A virus Ab [Presence] in Serum
8
162
0.49
1.36
1.0
1.1
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
27
175
1.55
1.35
1.3
1.3
mmol/l
64.4
64.6
0.01
18
135
(40760888) Immunoglobulin light chains.free panel - Serum
31
209
1.49
1.30
5.1
3.6
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
59
448
1.33
1.29
2.3
2.1
nmol/l
9.3
12.1
1.52
45
389
(3027944) Amphetamines [Presence] in Urine
21
329
0.63
1.28
1.7
1.5
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
10
48
2.09
1.28
1.7
1.3
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
29
195
1.50
1.24
1.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
29
195
1.50
1.24
1.0
1.1
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
34
0.00
1.16
0.0
1.2
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
8
154
0.52
1.14
1.1
1.2
nmol/l
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
14
233
0.60
1.12
1.3
1.4
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
131
1115
1.19
1.11
5.5
7.0
mmol/l
1.1
1.0
0.04
112
872
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
54
416
1.31
1.10
1.7
2.0
u/l
379.4
4308.1
2.12
17
161
(3037756) Immunofixation for Serum or Plasma
31
219
1.42
1.07
3.3
1.4
—
—
—
0
0
(3017704) Immunofixation for Urine
10
52
1.93
1.06
2.2
1.4
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
17
105
1.63
1.06
1.3
1.4
mosm/kgh2o
286.5
277.5
—
8
79
(3001964) Herpes simplex virus Ag [Presence] in Specimen
7
33
2.13
1.05
1.0
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
121
1416
0.84
1.05
1.8
1.7
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
216
1924
1.14
1.04
5.8
5.2
ug/l
1.9
2.3
1.14
165
1694
(3043238) Trisomy 21 risk [Likelihood] in Fetus
15
240
0.62
1.04
1.3
1.4
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
22
146
1.51
1.03
2.0
1.9
u/ml
20.6
31.5
0.14
22
140
(3036489) Thrombin time
54
422
1.29
1.01
1.4
1.8
s
21.5
21.3
0.04
49
362
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
26
180
1.45
1.01
1.6
1.2
u/l
32.6
19.9
0.47
20
153
(3025577) Chromium [Mass/volume] in Blood
12
68
1.77
1.00
1.9
2.1
ug/l
1.1
2.1
—
6
59
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
51
396
1.30
1.00
1.3
1.3
miu/ml
146.9
234.1
1.96
26
193
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
28
390
0.71
0.99
3.9
3.1
%
54.2
47.9
0.66
28
379
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
24
164
1.47
0.99
1.0
1.0
—
—
—
0
0
(1002224) Polysomnography panel
41
537
0.76
0.98
1.1
1.1
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
29
0.00
0.97
0.0
1.6
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
31
0.00
0.96
0.0
1.3
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
13
77
1.69
0.95
1.1
1.1
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
0
32
0.00
0.95
0.0
2.1
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
15
234
0.64
0.95
1.3
1.4
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
15
93
1.62
0.94
1.1
1.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
36
269
1.35
0.93
1.2
1.5
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
13
78
1.67
0.91
1.0
1.7
ug/l
5.0
7.6
0.85
13
64
(3024891) Influenza virus A+B Ag [Presence] in Specimen
40
306
1.32
0.89
1.1
1.1
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
59
727
0.80
0.89
1.6
1.3
iu/l
28.7
31.8
0.30
53
624
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
31
228
1.37
0.89
1.1
1.7
nmol/l
0.9
0.8
0.18
17
191
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
199
2212
0.88
0.88
3.0
2.6
mmol/l
2.4
2.4
0.36
170
1958
(3042111) Morphology [Interpretation] in Bone marrow Narrative
10
169
0.59
0.88
2.3
1.6
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
21
300
0.70
0.88
1.3
1.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1306
12849
1.13
0.86
5.2
4.8
mmol/l
2.9
2.9
0.07
1089
11872
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
14
213
0.65
0.81
1.4
1.8
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
95
1106
0.85
0.81
1.5
1.6
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
31
406
0.76
0.78
4.7
2.7
mmol/l
24.1
24.5
0.21
26
359
(3005322) IgE [Units/volume] in Serum or Plasma
97
835
1.17
0.78
1.3
1.2
u/ml
100.9
165.3
0.87
87
764
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
60
723
0.82
0.76
1.9
1.7
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
17
116
1.47
0.74
1.2
1.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
11
172
0.64
0.73
1.2
1.3
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
73
858
0.84
0.72
1.9
1.8
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
10
60
1.67
0.72
1.1
1.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
19
264
0.72
0.71
1.7
1.9
—
—
—
0
0
(3000492) Spirometry study
102
1164
0.87
0.70
1.5
1.5
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
7
41
1.71
0.70
1.1
1.5
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
16
110
1.46
0.68
1.1
1.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
7
118
0.59
0.68
2.0
1.7
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
107
1212
0.87
0.67
1.3
1.3
—
—
—
0
0
(44813793)
6
102
0.59
0.62
1.2
1.0
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
5
30
1.67
0.61
1.0
1.0
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
23
301
0.76
0.61
1.3
1.5
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
13
187
0.69
0.61
1.8
2.4
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
20
0.00
0.60
0.0
3.0
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
21
0.00
0.60
0.0
2.5
—
0.9
—
0
21
(3013139) Helicobacter pylori Ag [Presence] in Stool
101
894
1.14
0.60
1.2
1.2
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
22
0.00
0.59
0.0
1.4
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
16
114
1.41
0.59
1.1
1.1
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
11
162
0.68
0.58
1.1
1.4
pmol/l
560.5
320.4
—
6
121
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
23
175
1.32
0.58
1.2
1.5
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
74
848
0.87
0.57
2.6
4.1
%
0.1
0.5
0.41
50
185
(42529582) MDA5 Ab [Presence] in Serum by Line blot
6
36
1.67
0.56
1.5
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
6
36
1.67
0.56
1.5
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
6
36
1.67
0.56
1.5
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
6
36
1.67
0.56
1.5
1.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
20
150
1.34
0.56
1.1
1.1
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
8
122
0.65
0.55
1.1
1.2
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
12
82
1.47
0.54
1.6
1.6
u/l
1.6
5.8
—
5
40
(21494814) CD8 cells/100 lymphocytes in Specimen
6
38
1.58
0.54
1.3
2.1
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
9
61
1.48
0.53
2.7
1.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
27
338
0.80
0.53
2.6
1.5
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
13
181
0.72
0.52
1.2
1.4
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
9
64
1.41
0.51
1.2
1.3
nmol/l
157.7
128.0
—
9
64
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
25
197
1.27
0.51
1.2
1.2
u/ml
1.5
3.4
—
8
63
(3027008) Opiates [Presence] in Urine
27
335
0.80
0.50
2.5
1.5
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
27
335
0.80
0.50
2.5
1.5
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
25
313
0.80
0.50
2.6
1.5
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
16
119
1.35
0.48
1.1
1.2
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
11
76
1.45
0.48
1.4
1.6
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
7
50
1.40
0.45
1.0
2.8
%
124.9
134.0
—
7
50
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
23
183
1.26
0.45
1.1
1.2
iu/ml
1.0
3086.9
—
9
42
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
7
51
1.37
0.44
1.3
1.2
u/l
9.0
9.7
—
7
45
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
25
202
1.24
0.43
1.1
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
14
104
1.35
0.43
1.1
1.0
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
5
31
1.61
0.43
1.4
1.1
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
41
350
1.18
0.42
1.5
2.0
g/l
0.3
0.7
0.66
29
308
(3051101) Glucose [Moles/volume] in Cord blood
0
15
0.00
0.41
0.0
4.2
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
16
0.00
0.41
0.0
2.3
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
8
60
1.34
0.40
1.0
1.2
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
37
315
1.18
0.40
2.2
3.1
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
18
0.00
0.40
0.0
1.3
—
1.2
—
0
18
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
7
104
0.67
0.39
2.0
3.4
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
24
291
0.82
0.38
1.8
1.9
g/l
0.0
0.0
0.00
19
275
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
104
1130
0.91
0.37
3.5
3.1
ug/l
0.7
0.7
0.22
73
763
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
21
171
1.23
0.35
1.0
1.1
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
5
78
0.64
0.35
1.2
1.2
mmol/l
4.7
6.7
—
5
73
(3035880) pH of Pleural fluid
6
42
1.43
0.35
1.0
1.1
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
10
73
1.37
0.34
1.0
1.1
—
1.0
—
0
31
(3009466) Valproate [Moles/volume] in Serum or Plasma
19
154
1.24
0.34
4.9
5.4
umol/l
385.2
367.8
0.22
13
134
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
6
47
1.28
0.32
1.5
1.1
miu/ml
1286.0
1785.8
—
6
47
(3023430) Cat dander IgE Ab [Units/volume] in Serum
17
137
1.24
0.32
1.1
1.1
u/ml
1.4
3.5
—
5
46
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
89
820
1.09
0.31
1.4
1.4
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
20
165
1.22
0.31
1.4
1.5
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
7
52
1.35
0.31
4.1
3.0
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
7
53
1.32
0.31
2.0
2.9
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
43
381
1.13
0.30
1.5
1.9
g/l
3.0
3.0
0.08
24
306
(3025018) Bordetella pertussis Ab [Titer] in Serum
11
84
1.31
0.30
1.6
1.2
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
11
141
0.78
0.29
1.1
1.6
—
27.4
—
0
8
(3014133) Dog dander IgE Ab [Units/volume] in Serum
18
148
1.22
0.29
1.1
1.0
u/ml
0.6
2.6
—
5
47
(46235355) HIV 1 and 2 tests - Meaningful Use set
205
1955
1.06
0.29
1.8
1.7
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
15
184
0.81
0.28
1.2
1.3
nmol/l
0.6
0.6
0.06
15
178
(3023419) Bacteria identified in Sputum by Culture
9
118
0.76
0.27
2.0
2.8
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
40
356
1.13
0.27
1.9
1.9
iu/l
7.8
4.9
0.51
13
140
(3011985) Renin [Units/volume] in Plasma
14
172
0.81
0.27
1.4
1.4
mu/l
26.3
46.7
—
9
153
(3017181) Myelocytes/100 leukocytes in Blood
100
935
1.07
0.26
2.5
4.0
%
1.1
0.9
0.41
56
242
(3050129) First trimester maternal screen panel - Serum or Plasma
38
338
1.13
0.26
1.4
1.4
—
—
—
0
0
(3011648) Oxygen content in Venous blood
5
73
0.68
0.26
1.4
1.5
%
12.2
10.4
—
5
73
(3008898) HLA-B27 [Presence]
52
473
1.10
0.25
1.0
1.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
13
105
1.24
0.24
1.1
1.2
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
25
287
0.87
0.24
1.3
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
25
287
0.87
0.24
1.3
1.4
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
9
77
1.17
0.24
1.4
1.3
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
91
852
1.07
0.24
2.6
4.0
%
0.6
0.6
0.07
47
176
(3017817) Protein [Mass] in Urine collected for unspecified duration
6
84
0.71
0.24
4.2
2.1
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
25
286
0.87
0.24
1.3
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
25
286
0.87
0.24
1.3
1.4
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
44
399
1.11
0.23
1.5
1.8
g/l
7.5
7.3
0.26
29
316
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
44
399
1.11
0.23
1.5
1.8
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
17
143
1.19
0.23
1.3
1.5
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
18
211
0.85
0.23
1.2
1.2
—
—
—
0
0
(3034426) Prothrombin time (PT)
5
39
1.28
0.23
1.6
1.3
—
—
—
0
0
(3020891) Body temperature
47
430
1.10
0.21
4.1
4.0
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
5
42
1.19
0.21
4.8
1.4
—
—
—
0
0
(3042951) Complement C1q Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.2
—
26.9
—
0
6
(3036312) Salmon IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
0.0
—
0
5
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
10
0.00
0.21
0.0
1.1
—
7.8
—
0
10
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(46235168) Fasting glucose [Moles/volume] in Blood
0
12
0.00
0.21
0.0
1.0
—
5.7
—
0
5
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
8
102
0.78
0.21
1.1
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
8
102
0.78
0.21
1.1
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
8
102
0.78
0.21
1.1
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
8
103
0.78
0.21
1.1
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
8
103
0.78
0.21
1.1
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
8
103
0.78
0.21
1.1
1.1
—
—
—
0
0
(3019060) Gas panel - Arterial blood
67
625
1.08
0.20
3.7
4.0
—
—
—
0
0
(3041918) Cholesterol [Moles/volume] in Pleural fluid
0
14
0.00
0.20
0.0
1.1
—
1.8
—
0
8
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
14
0.00
0.20
0.0
10.6
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
36
326
1.11
0.20
1.6
1.8
g/l
39.8
38.6
0.54
22
284
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
122
1277
0.95
0.19
2.7
2.4
umol/l
7.0
6.2
0.26
100
1100
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
16
138
1.16
0.17
1.3
1.5
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
94
895
1.05
0.17
2.5
4.1
%
0.1
0.1
0.58
51
216
(3003888) Timothy IgE Ab [Units/volume] in Serum
21
186
1.13
0.17
1.1
1.1
u/ml
2.7
3.2
—
8
87
(3015183) Erythrocyte sedimentation rate
5
70
0.71
0.16
1.0
1.2
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
43
399
1.08
0.16
1.6
1.8
g/l
3.5
3.7
0.37
23
300
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
125
1202
1.04
0.15
1.8
1.7
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
22
197
1.12
0.15
1.5
1.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
1148
11547
0.97
0.15
14.7
12.2
%
38.9
39.5
1.45
681
8424
(44790047)
13
112
1.16
0.14
1.6
1.6
—
—
—
0
0
(44790049)
13
112
1.16
0.14
1.6
1.6
—
—
—
0
0
(44790048)
13
112
1.16
0.14
1.6
1.6
—
—
—
0
0
(44806118)
13
112
1.16
0.14
1.6
1.6
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
23
254
0.90
0.14
2.7
1.5
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
271
2769
0.97
0.13
1.4
1.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
66
694
0.95
0.13
1.3
1.4
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
363
3570
1.02
0.12
2.7
2.7
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
21
191
1.10
0.11
1.2
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
21
191
1.10
0.11
1.2
1.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
53
558
0.95
0.11
1.8
1.7
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
11
95
1.16
0.11
4.3
2.0
—
—
—
0
0
(3022621) pH of Urine by Test strip
82
788
1.04
0.11
3.2
2.6
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
20
182
1.10
0.11
1.2
1.1
u/ml
0.4
1.3
—
7
75
(4062490)
10
115
0.87
0.10
1.3
1.4
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
38
358
1.06
0.10
2.3
3.4
u/ml
32.6
448.7
0.55
32
302
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
5
44
1.14
0.10
2.0
1.8
u/ml
641.4
1207.4
—
5
44
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
5
48
1.04
0.09
1.0
1.0
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
7
64
1.09
0.08
1.0
1.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
7
65
1.08
0.08
1.6
1.1
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
7
66
1.06
0.08
1.1
1.5
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
8
74
1.08
0.07
1.4
1.3
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
7
84
0.83
0.07
1.1
1.1
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
20
214
0.93
0.07
1.2
1.1
u/ml
0.4
1.1
—
6
81
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
8
94
0.85
0.06
1.6
1.5
nmol/l
1.5
1.4
—
8
85
(3019832) Treponema pallidum Ab [Presence] in Serum
100
1023
0.98
0.06
1.5
1.5
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
28
294
0.95
0.06
1.7
1.9
g/l
0.0
0.0
0.00
20
276
(3023511) Choriogonadotropin [Units/volume] in Urine
25
237
1.06
0.05
1.3
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
37
384
0.96
0.05
1.2
1.2
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
10
110
0.91
0.05
2.4
1.7
—
—
—
0
0
(21494434) Karyotype in Bone marrow
10
91
1.10
0.04
1.1
1.2
—
—
—
0
0
(3000991) Gas panel - Venous blood
77
785
0.98
0.04
7.4
8.0
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
17
180
0.94
0.04
1.4
1.5
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
30
311
0.96
0.03
1.7
1.9
g/l
0.0
0.0
0.00
21
291
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
120
1216
0.99
0.03
1.2
1.4
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
14
131
1.07
0.03
1.4
1.6
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
238
2362
1.01
0.03
1.4
1.5
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
21
219
0.96
0.03
4.7
2.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
101
998
1.01
0.02
2.0
2.1
ml/min/173m2
70.8
71.9
0.08
27
396
(3014765) Yersinia sp identified in Stool by Organism specific culture
37
378
0.98
0.01
1.2
1.1
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
39
382
1.02
0.01
3.4
3.3
mmol/l
1.1
1.3
1.26
39
377
(44816559) Phosphatidylethanol [Mass/volume] in Blood
20
207
0.97
0.01
1.4
1.3
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
38
373
1.02
0.01
1.6
1.9
g/l
9.6
10.3
0.49
25
321
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
37
377
0.98
0.01
1.2
1.1
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
54
533
1.01
0.01
1.5
1.3
u/ml
0.2
1.1
—
5
48
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
20
206
0.97
0.00
1.3
1.2
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
10
104
0.96
0.00
1.4
1.5
g/l
1.0
1.0
—
10
104
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
16
162
0.99
0.00
1.4
1.5
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
156
1558
1.00
0.00
1.9
1.8
s
28.4
29.4
1.99
146
1510
(3026389) Candida sp identified in Specimen by Organism specific culture
16
163
0.98
0.00
1.8
1.4
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
20
203
0.99
0.00
2.6
2.4
mmol/l
25.9
25.2
0.38
20
180
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
28
277
1.01
0.00
2.0
2.4
ug/min
111.8
113.1
—
10
168
(3028707) Methadone [Presence] in Urine by Screen method
15
145
1.03
0.00
3.7
1.8
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
21
215
0.98
0.00
1.7
1.8
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
10
105
0.95
0.00
3.8
2.7
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis
0
6
0.00
0.00
0.0
7.7
—
23.5
—
0
6
(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
6
0.00
0.00
0.0
1.0
—
36.5
—
0
6
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
6
60
1.00
0.00
1.2
1.2
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.7
—
17.7
—
0
7
(3022725) Serotonin [Moles/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
971.0
—
0
5
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
9
97
0.93
0.00
1.2
1.6
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003531) Amoxicillin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.6
—
383.6
—
0
5
(46236302) HLA-C [Type] by High resolution typing
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
5
55
0.91
0.00
1.2
1.4
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
6
0.00
0.00
0.0
1.0
—
9.2
—
0
6
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
8
0.00
0.00
0.0
3.8
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(4212803)
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
8
0.00
0.00
0.0
7.5
—
—
—
0
0
(3013862) HLA-DP [Type]
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
9
91
0.99
0.00
1.2
1.4
—
1.5
—
0
6
(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
6
0.00
0.00
0.0
1.0
—
22.7
—
0
6
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
14.6
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: Z21_FOLLOW__CARE_INVOLVI_PLASTIC_SURGE – Follow-up care involving plastic surgery
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).